image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
a73d90e38bfd2173157fc5a6bff2c622d2c86c71b8936a150b531ea20b3abdd2.png | simple | <table><tr><td>NEO-PI-R scales</td><td>Never-smokers (<i>n </i>= 341)</td><td>Former-smokers (<i>n </i>= 429)</td><td>Current-smokers (<i>n </i>= 318)</td><td><i>F</i></td><td>Partial η<sup>2</sup></td></tr><tr><td>Neuroticism</td><td>48.9 (.51)<sup>a</sup></td><td>50.7 (.46)<sup>b</sup></td><td>51.6 (.55)<sup>b</... | <table><tr><td>NEO-PI-R scales</td><td>Never-smokers (n = 341)</td><td>Former-smokers (n = 429)</td><td>Current-smokers (n = 318)</td><td>F</td><td>Partial η2</td></tr><tr><td>Neuroticism</td><td>48.9 (.51)a</td><td>50.7 (.46)b</td><td>51.6 (.55)b</td><td>6.9**</td><td>.013</td></tr><tr><td>Extraversion</td><td>48.8 (.... | <table><tr><td>Openness</td><td>45.6 (.44)</td><td>46.4 (.39)</td><td>46.5 (.47)</td><td>1.2</td><td>.002</td></tr><tr><td>Agreeableness</td><td>50.9 (.49)</td><td>50.9 (.44)</td><td>49.9 (.52)</td><td>1.3</td><td>.002</td></tr><tr><td>Conscientiousness</td><td>49.4 (.52)a</td><td>49.0 (.46)a</td><td>47.0 (.55)b</td><t... |
ddeb5f0d47f26304e664602d0f7fef23117a41c1c2198a68774a4d23a97aebc6.png | simple | <table><tr><td></td><td>2D matrix</td><td><i>N</i><sub>avg</sub></td><td><i>N</i><sub>ti</sub></td><td><i>N</i><sub>si</sub></td><td><i>N</i><sub>ring</sub></td><td>N<sub>y</sub></td><td>SBW (Hz)</td><td><i>T</i><sub>acq</sub> (min:s)</td></tr><tr><td>EPSI</td><td>32 × 32</td><td>4</td><td>1</td><td>1</td><td>NA</... | <table><tr><td></td><td>2D matrix</td><td>Navg</td><td>Nti</td></tr><tr><td>EPSI</td><td>32 × 32</td><td>4</td><td>1</td></tr><tr><td>Re‐CRT</td><td>32 × 32</td><td>4</td><td>2</td></tr><tr><td>DW‐CRT with α = 1</td><td>32 × 32</td><td>1</td><td>2</td></tr><tr><td>DW‐CRT with α = 1.71</td><td>32 × 32</td><td>1</td><td>... | <table><tr><td>Nsi</td><td>Nring</td><td>Ny</td><td>SBW (Hz)</td><td>Tacq (min:s)</td></tr><tr><td>1</td><td>NA</td><td>32</td><td>2380</td><td>8:32</td></tr><tr><td>1</td><td>16</td><td>NA</td><td>2500</td><td>8:32</td></tr><tr><td>4</td><td>16</td><td>NA</td><td>2500</td><td>8:32</td></tr><tr><td>4</td><td>16</td><td... |
f5ac47aaef9468874ce3513b3a5555bd841dc7f2fffd134e7a7de7d782f6aeb9.png | simple | <table><tr><td></td><td><i>E.coli</i></td><td><i>S.typhimurium</i></td><td><i>Y.pestis</i></td><td><i>Y.enterocolitica</i></td><td><i>P.luminescens</i></td></tr><tr><td><i>E.coli</i></td><td>***</td><td>66.7</td><td>28.6</td><td>33.3</td><td>52.4</td></tr></table> | <table><tr><td></td><td>E.coli</td><td>S.typhimurium</td><td>Y.pestis</td><td>Y.enterocolitica</td><td>P.luminescens</td></tr></table> | <table><tr><td>E.coli</td><td>***</td><td>66.7</td><td>28.6</td><td>33.3</td><td>52.4</td></tr></table> |
74a8d57dfab4979f5fa1af0c51d217a7f8234f0c8273858b167ddbdb8eaf7f53.png | complex | <table><tr><td rowspan="2">Age</td><td colspan="6">Males</td><td colspan="6">Females</td></tr><tr><td>%</td><td>ASR</td><td>Offered/Uptake</td><td>% Uptake Rate</td><td>CI</td><td>Sig</td><td>%</td><td>ASR</td><td>Offered/Uptake</td><td>% Uptake Rate</td><td>CI</td><td>Sig</td></tr><tr><td>40-44</td><td>25.6</td><td>-5... | <table><tr><td rowspan="2">Age</td><td colspan="6">Males</td><td colspan="6">Females</td></tr><tr><td>%</td><td>ASR</td><td>Offered/Uptake</td><td>% Uptake Rate</td><td>CI</td><td>Sig</td><td>%</td><td>ASR</td><td>Offered/Uptake</td><td>% Uptake Rate</td><td>CI</td><td>Sig</td></tr><tr><td>40-44</td><td>25.6</td><td>-5... | <table><tr><td rowspan="2">Age</td><td colspan="6">Males</td><td colspan="6">Females</td></tr><tr><td>%</td><td>ASR</td><td>Offered/Uptake</td><td>% Uptake Rate</td><td>CI</td><td>Sig</td><td>%</td><td>ASR</td><td>Offered/Uptake</td><td>% Uptake Rate</td><td>CI</td><td>Sig</td></tr><tr><td></td><td>.4</td><td>-2.8</td>... |
149a2b64e6f721afc44b120dd3613a583e966af478ee4a9c3f9bd239a4efbb7b.png | simple | <table><tr><td>AE</td><td>Lacidipine (n = 162)</td><td>Amlodipine (n = 153)</td></tr><tr><td>Nervous system</td><td></td><td></td></tr><tr><td> Headache</td><td>3 (1.9)</td><td>6 (3.9)</td></tr><tr><td> Dizziness</td><td>2 (1.2)</td><td>1 (0.7)</td></tr><tr><td> Drowsiness</td><td>0</td><td>1 (0.7)</td></tr><tr><td> Ho... | <table><tr><td>AE</td><td>Lacidipine (n = 162)</td><td>Amlodipine (n = 153)</td></tr><tr><td>Nervous system</td><td></td><td></td></tr><tr><td>Headache</td><td>3 (1.9)</td><td>6 (3.9)</td></tr><tr><td>Dizziness</td><td>2 (1.2)</td><td>1 (0.7)</td></tr><tr><td>Drowsiness</td><td>0</td><td>1 (0.7)</td></tr><tr><td>Hoarse... | <table><tr><td>AE</td><td>Lacidipine (n = 162)</td><td>Amlodipine (n = 153)</td></tr><tr><td>With at least 1 AE</td><td>12 (7.4)</td><td>17 (11.1)</td></tr><tr><td>With no AEs</td><td>150 (92.6)</td><td>136 (88.9)</td></tr><tr><td>Withdrawn due to AEs</td><td>3 (1.9)</td><td>3 (2.0)</td></tr></table> |
ea4c0e8de3b165cb2c49cff704e8361b0632bca23b41e376b4b9d12c184579c8.png | simple | <table><tr><td>Species</td><td>Number of Retrocopies</td><td>Number of Parental Genes</td></tr><tr><td>Human</td><td>7,831</td><td>2,570</td></tr><tr><td>Chimpanzee</td><td>7,478</td><td>2,560</td></tr><tr><td>Gorilla</td><td>7,706</td><td>2,669</td></tr><tr><td>Orangutan</td><td>6,873</td><td>2,439</td></tr><tr><td>Rh... | <table><tr><td>Species</td><td>Number of Retrocopies</td><td>Number of Parental Genes</td></tr><tr><td>Human</td><td>7,831</td><td>2,570</td></tr><tr><td>Chimpanzee</td><td>7,478</td><td>2,560</td></tr></table> | <table><tr><td>Gorilla</td><td>7,706</td><td>2,669</td></tr><tr><td>Orangutan</td><td>6,873</td><td>2,439</td></tr><tr><td>Rhesus</td><td>7,502</td><td>2,453</td></tr><tr><td>Marmoset</td><td>10,465</td><td>3,067</td></tr><tr><td>Squirrel monkey</td><td>9,320</td><td>2,864</td></tr><tr><td>Mouse</td><td>7,109</td><td>2... |
e2cb400f2f6846bc79003f50b02b4ed27499888f5b08425fda25b395286d6492.png | simple | <table><tr><td> </td><td>HVLP group<i>N</i> = 20</td><td>Taper group<i>N</i> = 20</td></tr><tr><td>Age (years)</td><td>61.8 ± 12.9</td><td>64.9 ± 12.7</td></tr><tr><td>Gender (male/female)</td><td>10/10</td><td>10/10</td></tr><tr><td>Body weight (kg)</td><td>59.4 ± 13.7</td><td>57.3 ± 7.9</td></tr><... | <table><tr><td></td><td>HVLP groupN = 20</td></tr><tr><td>Age (years)</td><td>61.8 ± 12.9</td></tr><tr><td>Gender (male/female)</td><td>10/10</td></tr><tr><td>Body weight (kg)</td><td>59.4 ± 13.7</td></tr><tr><td>Height (cm)</td><td>161.6 ± 7.5</td></tr><tr><td>BMI (kg/m2)</td><td>22.6 ± 4.6</td></tr><tr><td>Mallampati... | <table><tr><td>Taper groupN = 20</td></tr><tr><td>64.9 ± 12.7</td></tr><tr><td>10/10</td></tr><tr><td>57.3 ± 7.9</td></tr><tr><td>159.5 ± 9.9</td></tr><tr><td>22.5 ± 2.5</td></tr><tr><td>7/12/1/0</td></tr><tr><td>9/11/0/0</td></tr><tr><td>3/7/8/2</td></tr></table> |
3bef57e6e39159b64b972d08f4a18a504ed3d959a84bc5f03140198fa1623c98.png | complex | <table><tr><td>Composition</td><td>Concentration</td></tr><tr><td>Sodium chloride (NaCl)</td><td>140 mM</td></tr><tr><td>HEPES</td><td>10 mM</td></tr><tr><td>Glucose</td><td>10 mM</td></tr><tr><td>Potassium chloride (KCl)</td><td>5 mM</td></tr><tr><td>Magnesium chloride (MgCl<sub>2</sub>)</td><td>1 mM</td></tr><tr><td>... | <table><tr><td>Composition</td><td>Concentration</td></tr><tr><td>Sodium chloride (NaCl)</td><td>140 mM</td></tr><tr><td>HEPES</td><td>10 mM</td></tr><tr><td>Glucose</td><td>10 mM</td></tr><tr><td>Potassium chloride (KCl)</td><td>5 mM</td></tr><tr><td>Magnesium chloride (MgCl2)</td><td>1 mM</td></tr><tr><td>Calcium chl... | <table><tr><td colspan="2">pH 7.4</td></tr><tr><td colspan="2">300 mOsm (310 for SMG)</td></tr></table> |
8c17f493bf4470a51ff4f2e5c6dceab108ba7baf55eaab19ef02958c915ab5bb.png | simple | <table><tr><td></td><td>Child normal weight</td><td>Child overweight*†</td><td>Child obese†</td></tr><tr><td></td><td>(n = 7349; 85%)</td><td>(n = 1272; 15%)</td><td>(n = 264; 3%)</td></tr><tr><td><i>Sociodemographic factors</i></td><td></td><td></td><td></td></tr><tr><td> Male sex (%)</td><td>51.2</td><td>... | <table><tr><td></td><td>Child normal weight</td><td>Child overweight*†</td></tr><tr><td></td><td>(n = 7349; 85%)</td><td>(n = 1272; 15%)</td></tr><tr><td>Sociodemographic factors</td><td></td><td></td></tr><tr><td>Male sex (%)</td><td>51.2</td><td>44.8‡</td></tr><tr><td>Both parents born outside Sweden (%)</td><td>28.7... | <table><tr><td>Child obese†</td></tr><tr><td>(n = 264; 3%)</td></tr><tr><td></td></tr><tr><td>46.2‡</td></tr><tr><td>34.2‡</td></tr><tr><td>19.9‡</td></tr><tr><td>22.1‡</td></tr><tr><td>41.9</td></tr><tr><td>7.5</td></tr><tr><td>15.5‡</td></tr><tr><td>54.4‡</td></tr><tr><td></td></tr><tr><td>49.3‡</td></tr><tr><td>73.7... |
03d5358a77f4856a31cf4081a968c91aa630b5a414cbb6545fc68be81de1268d.png | simple | <table><tr><td>Season</td><td>Similarity (%)</td><td>Nseqs</td><td>Sobs</td></tr><tr><td>amoA D∗</td><td>90</td><td>87</td><td>7</td></tr><tr><td>amoA T∗∗</td><td>90</td><td>82</td><td>3</td></tr></table> | <table><tr><td>Season</td><td>Similarity (%)</td><td>Nseqs</td><td>Sobs</td></tr><tr><td>amoA D∗</td><td>90</td><td>87</td><td>7</td></tr></table> | <table><tr><td>amoA T∗∗</td><td>90</td><td>82</td><td>3</td></tr></table> |
1e06d71778e6b005c1e9934b89e83f45e288971eb85426ad4eefa5e2ae124b05.png | simple | <table><tr><td>Artery size measurement method</td><td>Tortuosity < 0.1</td><td>All subjects</td></tr><tr><td>A</td><td>1.23 (1.09-1.34)</td><td>1.32 (1.24-1.40)</td></tr><tr><td>B</td><td>1.35 (1.20-1.46)</td><td>1.30 (1.13-1.42)</td></tr></table> | <table><tr><td>Artery size measurement method</td><td>Tortuosity < 0.1</td><td>All subjects</td></tr></table> | <table><tr><td>A</td><td>1.23 (1.09-1.34)</td><td>1.32 (1.24-1.40)</td></tr><tr><td>B</td><td>1.35 (1.20-1.46)</td><td>1.30 (1.13-1.42)</td></tr></table> |
8d5fdcc156ff00e75a31373e071d9238d98085bf0eec1202b95b912d67f4be37.png | simple | <table><tr><td>Pathway name</td><td># input genes in the pathway</td><td><i>P</i> value</td></tr><tr><td>Long adhesion</td><td>13</td><td>1.02<i>E</i> − 06</td></tr><tr><td>Long-term depression</td><td>6</td><td>3.85<i>E</i> − 04</td></tr><tr><td>ECM-receptor interaction</td><td>6</td><td>6.59<i>E</i> ͨ... | <table><tr><td>Pathway name</td><td># input genes in the pathway</td><td>P value</td></tr><tr><td>Long adhesion</td><td>13</td><td>1.02E − 06</td></tr><tr><td>Long-term depression</td><td>6</td><td>3.85E − 04</td></tr><tr><td>ECM-receptor interaction</td><td>6</td><td>6.59E − 04</td></tr><tr><td>Small cell lung cancer<... | <table><tr><td>Cell cycle</td><td>4</td><td>0.048272</td></tr><tr><td>B cell receptor signaling pathway</td><td>3</td><td>0.049885</td></tr><tr><td>Long-term potentiation</td><td>2</td><td>0.049885</td></tr><tr><td>Neurodegenerative diseases</td><td>2</td><td>0.050764</td></tr><tr><td>Wnt signaling pathway</td><td>7</t... |
afb8ed25ff0d1f54c3ed7b4ec9ea23519f0a42902373849b71b386b5e2ad234a.png | complex | <table><tr><td>Experimental Model/Method</td><td>Exposure</td><td>Mechanism of Resveratrol</td><td>Dosage of Resveratrol</td><td>Duration of Resveratrol Treatment</td><td>Reference</td></tr><tr><td>PC12 cells</td><td>Aβ<sub>25–35</sub> induced</td><td>attenuated Aβ-induced cytotoxicity, apoptotic featur... | <table><tr><td>Experimental Model/Method</td><td>Exposure</td><td>Mechanism of Resveratrol</td><td>Dosage of Resveratrol</td><td>Duration of Resveratrol Treatment</td><td>Reference</td></tr><tr><td>PC12 cells</td><td>Aβ25–35 induced</td><td>attenuated Aβ-induced cytotoxicity, apoptotic features, and intracellular ROI a... | <table><tr><td>Experimental Model/Method</td><td>Exposure</td><td>Mechanism of Resveratrol</td><td>Dosage of Resveratrol</td><td>Duration of Resveratrol Treatment</td><td>Reference</td></tr><tr><td rowspan="2">autophagy-related 5 knockdown HEK293</td><td rowspan="2">-</td><td>suppression of Presenilin-1 induction</td><... |
68c32bb1fd98c817c2f7eddd423128e5d32406e8e059ba1c4341facd9d81bdef.png | simple | <table><tr><td>Variable</td><td>Significance (p)</td><td>Relative risk</td><td>95% CI</td></tr><tr><td>Diabetes mellitus</td><td>0.009</td><td>4.0232</td><td>1.417–11.424</td></tr><tr><td>Duration of dialysis (years)</td><td>0.008</td><td>1.2499</td><td>1.059–1.475</td></tr></table> | <table><tr><td>Variable</td><td>Significance (p)</td><td>Relative risk</td><td>95% CI</td></tr></table> | <table><tr><td>Diabetes mellitus</td><td>0.009</td><td>4.0232</td><td>1.417–11.424</td></tr><tr><td>Duration of dialysis (years)</td><td>0.008</td><td>1.2499</td><td>1.059–1.475</td></tr></table> |
2352b20d449f01ca5d884c1eb3f3a1acc5185f579a139649a0364ddc5ea16d94.png | complex | <table><tr><td></td><td colspan="2">Treatment assignment</td><td colspan="2">Follow-up status</td></tr><tr><td></td><td>Calcium</td><td>Placebo</td><td>Included<sup>a</sup></td><td>Not included</td></tr><tr><td></td><td>(N = 334)</td><td>(N = 336)</td><td>(N = 563)</td><td>(N = 107)</td></tr><tr><td>Variable</td><td>Me... | <table><tr><td></td></tr><tr><td></td></tr><tr><td></td></tr><tr><td>Variable</td></tr><tr><td>Age (years)</td></tr><tr><td>Education (years)</td></tr><tr><td>Number of pregnancies</td></tr><tr><td>Number of children</td></tr><tr><td>Number of months previous breastfeeding (cumulative lifetime)</td></tr><tr><td>BMI (kg... | <table><tr><td colspan="2">Treatment assignment</td><td colspan="2">Follow-up status</td></tr><tr><td>Calcium</td><td>Placebo</td><td>Includeda</td><td>Not included</td></tr><tr><td>(N = 334)</td><td>(N = 336)</td><td>(N = 563)</td><td>(N = 107)</td></tr><tr><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td><td>Mea... |
f74448f78f14f02b8a2ad986cc3e6a7bfac69958c4d7502f2afdcd01f2ef6b6a.png | simple | <table><tr><td></td><td>"Successful" States</td><td>"Unsuccessful" States</td></tr><tr><td>Political arrangement</td><td>Varied: democracy (Senegal, multiparty), authoritarian (Uganda)</td><td>Varied: democracy (multiparty, Zambia), others including authoritarian (Namibia, Ethiopia)</td></tr><tr><td>Institutional struc... | <table><tr><td></td><td>"Successful" States</td><td>"Unsuccessful" States</td></tr></table> | <table><tr><td>Political arrangement</td><td>Varied: democracy (Senegal, multiparty), authoritarian (Uganda)</td><td>Varied: democracy (multiparty, Zambia), others including authoritarian (Namibia, Ethiopia)</td></tr><tr><td>Institutional structures</td><td>Centralised (now decentralising)</td><td>Varied (decentralised... |
1c7c9b2ea287278fd9ed6bb95398bf9aef3da82fccef9797f74117a2e0f8e6c0.png | simple | <table><tr><td>Method</td><td>Bias</td><td></td><td>MSE</td><td></td></tr><tr><td>LA</td><td>0.42</td><td>(0.14)</td><td>2.06</td><td>(0.21)</td></tr><tr><td>LDLA</td><td>0.31</td><td>(0.14)</td><td>2.15</td><td>(0.23)</td></tr><tr><td>LD decay</td><td>0.31</td><td>(0.14)</td><td>2.02</td><td>(0.21)</td></tr><tr><td>Tw... | <table><tr><td>Method</td><td>Bias</td><td></td><td>MSE</td><td></td></tr><tr><td>LA</td><td>0.42</td><td>(0.14)</td><td>2.06</td><td>(0.21)</td></tr><tr><td>LDLA</td><td>0.31</td><td>(0.14)</td><td>2.15</td><td>(0.23)</td></tr><tr><td>LD decay</td><td>0.31</td><td>(0.14)</td><td>2.02</td><td>(0.21)</td></tr></table> | <table><tr><td>Method</td><td>Bias</td><td></td><td>MSE</td><td></td></tr><tr><td>Two-marker</td><td>0.16</td><td>(0.13)</td><td>1.82</td><td>(0.18)</td></tr><tr><td>IBD</td><td>0.23</td><td>(0.13)</td><td>1.69</td><td>(0.20)</td></tr></table> |
55908da66535c91f52a09be154753b7ea3f415d19ae44b6c8d7352b944963841.png | complex | <table><tr><td>Autoimmune disease</td><td>Autoimmune target</td><td>Mean age of onset (range) years</td><td>Female:male ratio</td><td>Reference</td></tr><tr><td colspan="5">Mid-adult onset</td></tr><tr><td>Multiple sclerosis</td><td>Myelin sheath</td><td>37 (25–45)</td><td>1.8:1</td><td>(205)</td></tr><tr><td>Mya... | <table><tr><td>Autoimmune disease</td><td>Autoimmune target</td><td>Mean age of onset (range) years</td><td>Female:male ratio</td><td>Reference</td></tr><tr><td colspan="5">Mid-adult onset</td></tr><tr><td>Multiple sclerosis</td><td>Myelin sheath</td><td>37 (25–45)</td><td>1.8:1</td><td>(205)</td></tr><tr><td>Myastheni... | <table><tr><td>Autoimmune disease</td><td>Autoimmune target</td><td>Mean age of onset (range) years</td><td>Female:male ratio</td><td>Reference</td></tr><tr><td>Systemic lupus erythematosus</td><td>Nuclear contents (systemic)</td><td>40 (30–50)</td><td>9:1</td><td>(205, 206)</td></tr><tr><td>Neuromyelitis optica</td><t... |
b60e7ee57f4cbb70bf8f59dbfd29c03f9fe08969433eb3e29919dc8bab505da4.png | complex | <table><tr><td>COOH-MWCNTs</td><td>Criterion</td><td><i>E</i> (GPa)</td><td>σ<sub>u</sub> (MPa)</td><td><i>T</i>-3% (MPa.mm/mm)</td></tr><tr><td rowspan="2">0 wt% (neat)</td><td>Mean</td><td>21.70</td><td>320</td><td>6.70</td></tr><tr><td>STD</td><td>0.7</td><td>11.93</td><td>0.25</td></tr><tr><td rowspan="2">0.5 ... | <table><tr><td>COOH-MWCNTs</td><td>Criterion</td><td>E (GPa)</td><td>σu (MPa)</td><td>T-3% (MPa.mm/mm)</td></tr><tr><td rowspan="2">0 wt% (neat)</td><td>Mean</td><td>21.70</td><td>320</td><td>6.70</td></tr><tr><td>STD</td><td>0.7</td><td>11.93</td><td>0.25</td></tr><tr><td rowspan="2">0.5 wt%</td><td>Mean (% increase)<... | <table><tr><td>COOH-MWCNTs</td><td>Criterion</td><td>E (GPa)</td><td>σu (MPa)</td><td>T-3% (MPa.mm/mm)</td></tr><tr><td>1.0 wt%</td><td>STD</td><td>0.85</td><td>23.90</td><td>0.45</td></tr><tr><td rowspan="2">1.5 wt%</td><td>Mean (% increase)</td><td>20.40 (−6%)</td><td>344 (7%)</td><td>6.94 (3.48%)</td></tr><tr><td>ST... |
7a903216b3601da8344f4b13b30ea0fef2af4990efcfd461832c941fd53727f4.png | complex | <table><tr><td></td><td colspan="2">ARC</td><td colspan="4">WHOQOL-BREF</td><td colspan="4">Social Network</td></tr><tr><td>Variable</td><td>Personal</td><td>Social</td><td>Physical</td><td>Psych</td><td>Social</td><td>Enviro</td><td>Group substance use</td><td>Non-using groups identification</td><td>Heavy using groups... | <table><tr><td></td><td colspan="2">ARC</td><td colspan="4">WHOQOL-BREF</td><td colspan="4">Social Network</td></tr><tr><td>Variable</td><td>Personal</td><td>Social</td><td>Physical</td><td>Psych</td><td>Social</td><td>Enviro</td><td>Group substance use</td><td>Non-using groups identification</td><td>Heavy using groups... | <table><tr><td></td><td colspan="2">ARC</td><td colspan="4">WHOQOL-BREF</td><td colspan="4">Social Network</td></tr><tr><td>Variable</td><td>Personal</td><td>Social</td><td>Physical</td><td>Psych</td><td>Social</td><td>Enviro</td><td>Group substance use</td><td>Non-using groups identification</td><td>Heavy using groups... |
14b6384f6dc41ac2f591644f27c9601a8c391cef5433361bd313326e0f69638a.png | simple | <table><tr><td>Study</td><td> </td><td>Number</td><td>Metabolic syndrome</td><td>Htn</td><td>High TG</td><td>Impaired FBS</td><td>Low HDL</td><td>High WC</td></tr><tr><td>Iran</td><td>Gorgan</td><td>100</td><td>31%</td><td>16%</td><td>16%</td><td>17%</td><td>30%</td><td>29%</td></tr><tr><td> </td><td>North East</td><td... | <table><tr><td>Study</td><td></td><td>Number</td><td>Metabolic syndrome</td><td>Htn</td><td>High TG</td><td>Impaired FBS</td><td>Low HDL</td><td>High WC</td></tr><tr><td>Iran</td><td>Gorgan</td><td>100</td><td>31%</td><td>16%</td><td>16%</td><td>17%</td><td>30%</td><td>29%</td></tr></table> | <table><tr><td>Study</td><td></td><td>Number</td><td>Metabolic syndrome</td><td>Htn</td><td>High TG</td><td>Impaired FBS</td><td>Low HDL</td><td>High WC</td></tr><tr><td></td><td>North East</td><td>160</td><td>20.62%</td><td>3.12%</td><td>20%</td><td>14.30%</td><td>29.37%</td><td>34.37%</td></tr><tr><td></td><td>Babol<... |
01f15db8eb9fb767f8b78df5e1bcd884999c51bc4dc7af4ed65a3e6379868312.png | simple | <table><tr><td>Genome Effect</td></tr><tr><td>Changes in ploidy (mostly WGD)</td></tr><tr><td>Alteration of epigenetic modifications to the genome</td></tr><tr><td>Alterations in expression patterns across the genome</td></tr><tr><td>Activation and spread of mobile DNA elements</td></tr><tr><td>Genome restructuring inv... | <table><tr><td>Genome Effect</td></tr><tr><td>Changes in ploidy (mostly WGD)</td></tr><tr><td>Alteration of epigenetic modifications to the genome</td></tr><tr><td>Alterations in expression patterns across the genome</td></tr><tr><td>Activation and spread of mobile DNA elements</td></tr><tr><td>Genome restructuring inv... | <table><tr><td>romeres</td></tr></table> |
38557d1b0629b5159d4350b523d412e2ede1fd85708d2862f731d07abdb73593.png | complex | <table><tr><td>Insomnia</td><td>With (<i>N</i> = 159,989)</td><td>Without (<i>N</i> = 319,979)</td><td rowspan="2"><i>P</i>-value</td></tr><tr><td><i>X</i>-year(s) of suicide attempts</td><td colspan="2">Numbers of suicide attempts</td></tr><tr><td>1</td><td>285</td><td>101</td><td>< 0.001</td></tr><tr><td>2</td><td... | <table><tr><td>Insomnia</td><td>With (N = 159,989)</td><td>Without (N = 319,979)</td><td rowspan="2">P-value</td></tr><tr><td>X-year(s) of suicide attempts</td><td colspan="2">Numbers of suicide attempts</td></tr><tr><td>1</td><td>285</td><td>101</td><td>< 0.001</td></tr><tr><td>2</td><td>525</td><td>157</td><td>< 0.00... | <table><tr><td>10</td><td>1084</td><td>296</td><td>< 0.001</td></tr><tr><td>11</td><td>1198</td><td>297</td><td>< 0.001</td></tr><tr><td>12</td><td>1198</td><td>297</td><td>< 0.001</td></tr><tr><td>13</td><td>1198</td><td>297</td><td>< 0.001</td></tr></table> |
c9856ab54ee1c51f132148c1aecf55fc8edf1d8022d53278f9fffd2e421d1d83.png | complex | <table><tr><td>Determinant</td><td>Ready to enroll/re-enroll, <i>n</i> (%)</td><td><i>P</i>-Value</td><td>COR</td><td>AOR</td></tr><tr><td colspan="5">Region CHF enrolment rate</td></tr><tr><td> Low</td><td>186(81.6)</td><td>0.513</td><td>1</td><td></td></tr><tr><td> High</td><td>190(81.9)</td><td></td><td>1.0(0.6-1.6)... | <table><tr><td>Determinant</td><td>Ready to enroll/re-enroll, n (%)</td><td>P-Value</td><td>COR</td><td>AOR</td></tr><tr><td colspan="5">Region CHF enrolment rate</td></tr><tr><td>Low</td><td>186(81.6)</td><td>0.513</td><td>1</td><td></td></tr><tr><td>High</td><td>190(81.9)</td><td></td><td>1.0(0.6-1.6)</td><td></td></... | <table><tr><td>Male</td><td>157(78.5)</td><td>0.073</td><td>1</td><td>1</td></tr><tr><td>Female</td><td>219(58.2)</td><td></td><td>1.5(0.9-2.4)a</td><td>1.4(0.8-2.2)</td></tr><tr><td colspan="5">Age group</td></tr><tr><td>< 35 years</td><td>218(83.5)</td><td>0.155</td><td>1</td><td></td></tr><tr><td>35+ years</td><td>1... |
7972ff1e505b825ba512f3ed0b96e601bc8621b06c46a59a17c406c5d7845808.png | simple | <table><tr><td>All subjects (<i>N</i>=30)</td><td>6.25-12.5 Hz</td><td>12.5-25 Hz</td><td>25-50 Hz</td></tr><tr><td>Global Efficiency</td><td>-0.13</td><td>-0.25</td><td>0.15</td></tr><tr><td>Local Efficiency</td><td>-0.21</td><td>-0.33</td><td>0.08</td></tr><tr><td>Interdensity</td><td>-0.15</td><td>-0.13</td><td>0.02... | <table><tr><td>All subjects (N=30)</td><td>6.25-12.5 Hz</td><td>12.5-25 Hz</td><td>25-50 Hz</td></tr><tr><td>Global Efficiency</td><td>-0.13</td><td>-0.25</td><td>0.15</td></tr><tr><td>Local Efficiency</td><td>-0.21</td><td>-0.33</td><td>0.08</td></tr><tr><td>Interdensity</td><td>-0.15</td><td>-0.13</td><td>0.02</td></... | <table><tr><td>All subjects (N=30)</td><td>6.25-12.5 Hz</td><td>12.5-25 Hz</td><td>25-50 Hz</td></tr><tr><td>Local Efficiency</td><td>-0.26</td><td>* -0.66</td><td>-0.20</td></tr><tr><td>Interdensity</td><td>0.08</td><td>-0.21</td><td>0.01</td></tr><tr><td>Intradensity Unaffected Hemi</td><td>-0.24</td><td>* -0.75</td>... |
2e22f0e33379969097d165792570d753a216b06699477a9a3c542c544acf37a1.png | simple | <table><tr><td>Significant consensus genes from continuous and extreme data, excluding children data</td><td>No. of overlap</td><td>No. not overlapping</td><td>% Overlap</td></tr><tr><td>Single-probe analysis</td><td>232</td><td>9085</td><td>2.49</td></tr><tr><td>Region analysis</td><td>39</td><td>364</td><td>9.70</td>... | <table><tr><td>Significant consensus genes from continuous and extreme data, excluding children data</td></tr><tr><td>Single-probe analysis</td></tr><tr><td>Region analysis</td></tr></table> | <table><tr><td>No. of overlap</td><td>No. not overlapping</td><td>% Overlap</td></tr><tr><td>232</td><td>9085</td><td>2.49</td></tr><tr><td>39</td><td>364</td><td>9.70</td></tr></table> |
611447fd04c958aeafc15152365dd8f0a00054ce48b00b04db87f8c2b1b5980e.png | complex | <table><tr><td colspan="5">P-values for small group</td></tr><tr><td>Genes in small group</td><td>Known genes</td><td>Known genes in data set</td><td>Genes in data set</td><td>P-value</td></tr><tr><td>6</td><td>2</td><td>7</td><td>129</td><td>0.0342</td></tr><tr><td>50</td><td>6</td><td>7</td><td>129</td><td>0.0136</td... | <table><tr><td colspan="4">P-values for small group</td></tr><tr><td>Genes in small group</td><td>Known genes</td><td>Known genes in data set</td><td>Genes in data set</td></tr><tr><td>6</td><td>2</td><td>7</td><td>129</td></tr><tr><td>50</td><td>6</td><td>7</td><td>129</td></tr></table> | <table><tr><td>P-values for small group</td></tr><tr><td>P-value</td></tr><tr><td>0.0342</td></tr><tr><td>0.0136</td></tr></table> |
edd7458a50ce7b1a2bf4462f6a625e80c3af937460c5cbc9fb9ba65c8ddbd99d.png | simple | <table><tr><td>Region</td><td>PS-DHA</td><td>Placebo</td><td><i>p</i> Value</td></tr><tr><td>Left Frontal Cortex</td><td>52.23 ± 1.31</td><td>42.89 ± 0.94</td><td>0.054</td></tr><tr><td>Right Frontal Cortex</td><td>51.67 ± 1.22</td><td>37.69 ± 0.76</td><td>0.011</td></tr><tr><td>Left Hippocampus</td... | <table><tr><td>Region</td><td>PS-DHA</td><td>Placebo</td><td>p Value</td></tr><tr><td>Left Frontal Cortex</td><td>52.23 ± 1.31</td><td>42.89 ± 0.94</td><td>0.054</td></tr><tr><td>Right Frontal Cortex</td><td>51.67 ± 1.22</td><td>37.69 ± 0.76</td><td>0.011</td></tr><tr><td>Left Hippocampus</td><td>59.50 ± 2.93</td><td>3... | <table><tr><td>Region</td><td>PS-DHA</td><td>Placebo</td><td>p Value</td></tr><tr><td>Thalamus</td><td>47.24 ± 0.58</td><td>36.25 ± 0.07</td><td>0.004</td></tr><tr><td>Corpus Callosum</td><td>49.34 ± 0.79</td><td>31.23 ± 0.27</td><td>0.059</td></tr><tr><td>Left Internal Capsule</td><td>43.77 ± 0.64</td><td>30.60 ± 0.38... |
c63f6c0c456bc1052327ab4c5c0e46590e3a7b437e4175322387afe627ddf94d.png | simple | <table><tr><td> </td><td>B</td><td>SE B</td><td>OR</td><td>[95% CI]</td><td>p-value</td></tr><tr><td>Child’s BMI, kg/ <i>m</i><sup>2</sup></td><td>.63</td><td>.06</td><td>1.88</td><td>[1.66, 2.13]</td><td>.000</td></tr><tr><td>Migration background(child), <i>yes</i></td><td>.47</td><td>.20</td><td>1.60</td><td>[1... | <table><tr><td></td><td>B</td><td>SE B</td><td>OR</td><td>[95% CI]</td><td>p-value</td></tr><tr><td>Child’s BMI, kg/ m2</td><td>.63</td><td>.06</td><td>1.88</td><td>[1.66, 2.13]</td><td>.000</td></tr></table> | <table><tr><td></td><td>B</td><td>SE B</td><td>OR</td><td>[95% CI]</td><td>p-value</td></tr><tr><td>Migration background(child), yes</td><td>.47</td><td>.20</td><td>1.60</td><td>[1.07, 2.37]</td><td>.020</td></tr><tr><td>Self-efficacy to influencechild’s physical activity,high</td><td>-.54</td><td>.19</td><td>0.58</td>... |
3f83b920fb99d3228b09008decd9ed1d76dbbf6e5d6c8295c345085d9c3ccbb3.png | complex | <table><tr><td></td><td colspan="5">Univariate analysis</td><td colspan="3">Multivariate</td></tr><tr><td></td><td>Gametocytes</td><td>No gametocytes</td><td>OR</td><td>95% CI</td><td>P value</td><td>OR</td><td>95% CI</td><td>P value</td></tr><tr><td>Placental malaria (haemozoin or qPCR)</td><td>14/15 (93.3%)</td><td>8... | <table><tr><td></td><td colspan="5">Univariate analysis</td></tr><tr><td></td><td>Gametocytes</td><td>No gametocytes</td><td>OR</td><td>95% CI</td><td>P value</td></tr><tr><td>Placental malaria (haemozoin or qPCR)</td><td>14/15 (93.3%)</td><td>89/295 (30.2%)</td><td>32.4</td><td>4.2 - 250.2</td><td><0.01</td></tr><tr><... | <table><tr><td colspan="3">Multivariate</td></tr><tr><td>OR</td><td>95% CI</td><td>P value</td></tr><tr><td>--</td><td>--</td><td>--</td></tr><tr><td>10.3</td><td>1.9 – 55.1</td><td><0.01</td></tr><tr><td>2.8</td><td>0.8 – 9.3</td><td>0.09</td></tr><tr><td>1.1</td><td>0.7 – 1.5</td><td>0.76</td></tr><tr><td>1.4</td><td... |
aa85619eb39fed838e986366d1c4afd3749dad4a0c226b220916fa9d52b3e5ce.png | simple | <table><tr><td>Comparison and protein</td><td>Entrez gene name</td><td><i>P</i> value</td><td>Fold change</td></tr><tr><td>LMP1 vs pBabe: no inhibitors (<i>P</i> = 1.92E−05)</td><td></td><td></td><td></td></tr><tr><td>DNAJC7</td><td>DnaJ (Hsp40) homologue, subfamily C, member 7</td><td>3.90E−02</td><td>W... | <table><tr><td>Comparison and protein</td><td>Entrez gene name</td><td>P value</td><td>Fold change</td></tr><tr><td>LMP1 vs pBabe: no inhibitors (P = 1.92E−05)</td><td></td><td></td><td></td></tr><tr><td>DNAJC7</td><td>DnaJ (Hsp40) homologue, subfamily C, member 7</td><td>3.90E−02</td><td>−1.852</td></tr><tr><td>HSPA14... | <table><tr><td>BAG1</td><td>BCL2-associated athanogene</td><td>2.96E−03</td><td>2.613</td></tr><tr><td>BIRC3</td><td>Baculoviral IAP repeat-containing 3</td><td>1.58E−02</td><td>−1.760</td></tr><tr><td>CUL1</td><td>Cullin-1</td><td>3.57E−03</td><td>−1.414</td></tr><tr><td>DNAJC5</td><td>DnaJ (Hsp40) homologue, subfamil... |
3d6e895822b608325ac303c383c4be3898a3aebbb76e3d737ffb19b80b081f6b.png | simple | <table><tr><td>CRHR1 antagonist</td><td>Studies</td><td>Dosage</td><td>Outcome</td><td>Comments</td></tr><tr><td>Antalarmin</td><td>Rissman et al. (2012) [59], Dong et al. (2014) [43], Park et al. (2015) [44],</td><td>20 mg/kg</td><td>Rissman (2012) - Able to block acute stress induced tau phosphorylation but not that ... | <table><tr><td>CRHR1 antagonist</td><td>Studies</td><td>Dosage</td><td>Outcome</td><td>Comments</td></tr><tr><td>Antalarmin</td><td>Rissman et al. (2012) [59], Dong et al. (2014) [43], Park et al. (2015) [44],</td><td>20 mg/kg</td><td>Rissman (2012) - Able to block acute stress induced tau phosphorylation but not that ... | <table><tr><td>CRHR1 antagonist</td><td>Studies</td><td>Dosage</td><td>Outcome</td><td>Comments</td></tr><tr><td>NBI27914</td><td>Park et al. (2015) [44], Lee et al. (2009) [83], Carroll et al. (2011) [54]</td><td>10 mg/kg</td><td>Carroll (2011) [54] - NBI27914 rescued freezing and decreased AT8 phosphorylation and dec... |
95e0de98b226da026797a851cac5d02bf96adc267856495440936f1d36fda515.png | simple | <table><tr><td>d— difference between G values</td><td>Selection rate2.5 %</td><td>5.0 %</td><td>10.0 %</td><td>Effect of divergent selection (χ<sup>2</sup> test)</td></tr><tr><td>3 %</td><td>1.8-2.0</td><td>1.6-1.9</td><td>1.6-2.0</td><td>Not significant at any of the tested selection rates</td></tr><tr><td>... | <table><tr><td>d— difference between G values</td><td>Selection rate2.5 %</td><td>5.0 %</td><td>10.0 %</td><td>Effect of divergent selection (χ2 test)</td></tr></table> | <table><tr><td>3 %</td><td>1.8-2.0</td><td>1.6-1.9</td><td>1.6-2.0</td><td>Not significant at any of the tested selection rates</td></tr><tr><td>5 %</td><td>2.7-4.2*</td><td>2.1-3.2</td><td>1.9-2.2</td><td>Significant at 2.5 % selection rate</td></tr><tr><td>7.5 %</td><td>3.5-5.5*</td><td>2.5-3.1</td><td>2.3-2.5</td><t... |
e5ca10404db7759e0a43807095067e2c4ccb5333147f81e79ec6a811798b838d.png | simple | <table><tr><td>Variable</td><td>Descriptive statistic</td></tr><tr><td>Age</td><td>27.1 ± 5.8 years</td></tr><tr><td>Age group</td><td></td></tr><tr><td>15–24</td><td>37.8%</td></tr><tr><td>25–34</td><td>48.3%</td></tr><tr><td>35–44</td><td>13.5%</td></tr><tr><td>< 15 and > 44</td><td>0.4%<... | <table><tr><td>Variable</td><td>Descriptive statistic</td></tr><tr><td>Age</td><td>27.1 ± 5.8 years</td></tr><tr><td>Age group</td><td></td></tr><tr><td>15–24</td><td>37.8%</td></tr><tr><td>25–34</td><td>48.3%</td></tr><tr><td>35–44</td><td>13.5%</td></tr></table> | <table><tr><td>< 15 and > 44</td><td>0.4%</td></tr><tr><td>Marital status</td><td></td></tr><tr><td>Married</td><td>86.9%</td></tr><tr><td>Single</td><td>12.0%</td></tr><tr><td>Widow or separated or divorced</td><td>1.2%</td></tr><tr><td>Years of formal education</td><td>10.3 ± 3.3 years</td></tr><tr><td>None</td><td>0... |
2fc24236435bbfd06eeb3db9381927642d84488d4b902e197faaa59a4b6d191c.png | complex | <table><tr><td>Gene Name</td><td>Primer Sequence</td><td>Length of Product (bp)</td></tr><tr><td colspan="3">Reverse Transcription Quantitative PCR (RT-qPCR)</td></tr><tr><td rowspan="2"><i>CmCHS1</i></td><td>F: CTGGAACAGCAACGGAAACT</td><td rowspan="2">190</td></tr><tr><td>R: TCCGTTGTTGATGAGCCAGA</td></tr><tr><td rowsp... | <table><tr><td>Gene Name</td><td>Primer Sequence</td><td>Length of Product (bp)</td></tr><tr><td colspan="3">Reverse Transcription Quantitative PCR (RT-qPCR)</td></tr><tr><td rowspan="2">CmCHS1</td><td>F: CTGGAACAGCAACGGAAACT</td><td rowspan="2">190</td></tr><tr><td>R: TCCGTTGTTGATGAGCCAGA</td></tr><tr><td rowspan="2">... | <table><tr><td rowspan="6">CmCHSA</td><td>F1: ACTATGTGGCACGAAACGAA</td><td rowspan="2">354</td></tr><tr><td>R1: TAGTACATGTACAT</td></tr><tr><td>F2: CATTTGAAAGATAAGGC</td><td rowspan="2">580</td></tr><tr><td>R2: ACCAACATRAGRAADAT</td></tr><tr><td>F3: CGCCTTACATCGCTTACC</td><td rowspan="2">1258</td></tr><tr><td>R3: ACBAR... |
8e0eb7c8536c50f35d8c22b3b58e15770bcdbb3176439ae6f57c00fee24113be.png | simple | <table><tr><td>Oligonucleotide designation</td><td>Oligonucleotide (5′→3′)</td><td>Genome position</td></tr><tr><td>p1167</td><td>ACCCTACTGACTGACGAACAGATTGCTTC</td><td>6816−6847</td></tr><tr><td>p1168</td><td>TGTTGTTGAGCGTAATGAGTCCGTCCT</td><td>6230–6256</td></tr><tr><td>p1303</td><td>GTCT... | <table><tr><td>Oligonucleotide designation</td><td>Oligonucleotide (5′→3′)</td><td>Genome position</td></tr><tr><td>p1167</td><td>ACCCTACTGACTGACGAACAGATTGCTTC</td><td>6816−6847</td></tr><tr><td>p1168</td><td>TGTTGTTGAGCGTAATGAGTCCGTCCT</td><td>6230–6256</td></tr><tr><td>p1303</td><td>GTCTTGTCAAACGTTTATAATCTATGGCAAATAC... | <table><tr><td>p1338</td><td>ATTGCTCACCCTTGTTGGGAACGTTACCCTT</td><td>1303–1333</td></tr><tr><td>p1343</td><td>AACTTAAACCTTTCGACACTTGGGAAGAAGTA</td><td>7001–7032</td></tr><tr><td>p1362</td><td>AACGGCACAATAGTCATCGTCCCG</td><td>6469–6492</td></tr><tr><td>p1363T</td><td>TGGCCGTCATGGTGGCGAATAATGTCAACCTAATCT-ACGGTAAGATGAGTCT... |
a495d4169426b1b2877b7a5df27d937331138b6315889bb2b47b32f6da60929f.png | complex | <table><tr><td>Condition</td><td>Brain region</td><td colspan="3">MNI coordinate</td><td>BA</td><td><i>T</i>-value</td></tr><tr><td></td><td></td><td><i>x</i></td><td><i>y</i></td><td><i>z</i></td><td></td><td></td></tr><tr><td>Resting-state</td><td>PCC</td><td>−6</td><td>−60</td><td>28</td><td>31</td><td>1... | <table><tr><td>Condition</td><td>Brain region</td><td colspan="3">MNI coordinate</td><td>BA</td></tr><tr><td></td><td></td><td>x</td><td>y</td><td>z</td><td></td></tr><tr><td>Resting-state</td><td>PCC</td><td>−6</td><td>−60</td><td>28</td><td>31</td></tr><tr><td></td><td>Left IPC (lIPC)</td><td>−42</td><td>−66</td><td>... | <table><tr><td>T-value</td></tr><tr><td></td></tr><tr><td>18.17</td></tr><tr><td>15.45</td></tr><tr><td>10.97</td></tr><tr><td>9.25</td></tr><tr><td>7.43</td></tr><tr><td>6.43</td></tr><tr><td>5.82</td></tr><tr><td>6.77</td></tr><tr><td>15.81</td></tr><tr><td>9.38</td></tr><tr><td>15.18</td></tr><tr><td>5.12</td></tr><... |
82cc1ed00f12de5b1375c8e1a8fda6e1e53001be4c269ab1235439b464bdf364.png | complex | <table><tr><td rowspan="2">SSR Pattern</td><td rowspan="2">SSR Numbers in Non-redundant White Clover ESTs</td><td rowspan="2">Frequency (%)</td><td colspan="4">Designed EST-SSR Primers</td></tr><tr><td>Mismatch 0</td><td>Mismatch 1</td><td>Mismatch 2</td><td>Total</td></tr><tr><td>AG</td><td>211</td><td>16.67</td><td>3... | <table><tr><td rowspan="2">SSR Pattern</td><td rowspan="2">SSR Numbers in Non-redundant White Clover ESTs</td><td rowspan="2">Frequency (%)</td><td colspan="4">Designed EST-SSR Primers</td></tr><tr><td>Mismatch 0</td><td>Mismatch 1</td><td>Mismatch 2</td><td>Total</td></tr><tr><td>AG</td><td>211</td><td>16.67</td><td>3... | <table><tr><td rowspan="2">SSR Pattern</td><td rowspan="2">SSR Numbers in Non-redundant White Clover ESTs</td><td rowspan="2">Frequency (%)</td><td colspan="4">Designed EST-SSR Primers</td></tr><tr><td>Mismatch 0</td><td>Mismatch 1</td><td>Mismatch 2</td><td>Total</td></tr><tr><td>TAG</td><td>8</td><td>.63</td><td></td... |
09187983631a73f69d4db2bec52f2208bbd91df03e0be75149b33626a5d9e811.png | complex | <table><tr><td></td><td>Informant</td><td>Area of expertise</td><td>Recruitment</td><td>Interview setting</td><td>Informant characteristics</td></tr><tr><td rowspan="4">STEP 1 EXPERTS (<i>N</i> = 4) (key informant interviews)</td><td>Professor Peter Krustrup (PK)</td><td>Extensive knowledge and experience in human phys... | <table><tr><td></td><td>Informant</td></tr><tr><td rowspan="4">STEP 1 EXPERTS (N = 4) (key informant interviews)</td><td>Professor Peter Krustrup (PK)</td></tr><tr><td>Professor Klaus Brasso (KB)</td></tr><tr><td>Dr. Svend Aage Madsen (SM)</td></tr><tr><td>Professor Michael Borre (MB)</td></tr></table> | <table><tr><td>Area of expertise</td><td>Recruitment</td><td>Interview setting</td><td>Informant characteristics</td></tr><tr><td>Extensive knowledge and experience in human physiology and soccer research</td><td>Personal contact at a meeting</td><td>The informant’s office</td><td>Professor of Team Sport and Health; ma... |
2a8adb2d014b068dd17e0f247e1ebbf66bf16448955506a6c0973e4e0ca0b02d.png | complex | <table><tr><td></td><td>Est</td><td>SE</td><td>β</td><td>p</td><td>Lower CI</td><td>Upper CI</td><td>FMI</td><td>Δ R<sup>2</sup></td></tr><tr><td colspan="8">MVPA: (F(9,171) = 1.97, R<sup>2=</sup>.09)</td><td></td></tr><tr><td>(Intercept)</td><td>19.22</td><td>18.56</td><td>0.00</td><td>0.30</td><td>−17... | <table><tr><td></td><td>Est</td><td>SE</td><td>β</td><td>p</td><td>Lower CI</td><td>Upper CI</td><td>FMI</td><td>Δ R2</td></tr><tr><td colspan="8">MVPA: (F(9,171) = 1.97, R2=.09)</td><td></td></tr><tr><td>(Intercept)</td><td>19.22</td><td>18.56</td><td>0.00</td><td>0.30</td><td>−17.16</td><td>55.60</td><td>0.06</td><td... | <table><tr><td></td><td>Est</td><td>SE</td><td>β</td><td>p</td><td>Lower CI</td><td>Upper CI</td><td>FMI</td><td>Δ R2</td></tr><tr><td>Nurturance</td><td>0.44</td><td>1.85</td><td>0.02</td><td>0.81</td><td>−3.19</td><td>4.07</td><td>0.08</td><td rowspan="3">Social = .012</td></tr><tr><td>Limit-setting</td><td>0.99</td>... |
c50a7c999a75218f6a216d11413e07f88719a911932a1f0800d36e0f4ca39671.png | simple | <table><tr><td></td><td>Foot pain in last month n (%)</td><td>No foot pain in last month n (%)</td><td>Unadjusted OR (95 % CI)</td><td>Adjusted<sup>a</sup> OR (95 % CI)</td></tr><tr><td>N</td><td>248</td><td>875</td><td>-</td><td>-</td></tr><tr><td>Age, mean (SD)</td><td>66.6 (11.7)</td><td>65.0 (12.7)</td><td>1.11<sup... | <table><tr><td></td><td>Foot pain in last month n (%)</td><td>No foot pain in last month n (%)</td><td>Unadjusted OR (95 % CI)</td><td>Adjusteda OR (95 % CI)</td></tr><tr><td>N</td><td>248</td><td>875</td><td>-</td><td>-</td></tr><tr><td>Age, mean (SD)</td><td>66.6 (11.7)</td><td>65.0 (12.7)</td><td>1.11b (0.99, 1.24)<... | <table><tr><td></td><td>Foot pain in last month n (%)</td><td>No foot pain in last month n (%)</td><td>Unadjusted OR (95 % CI)</td><td>Adjusteda OR (95 % CI)</td></tr><tr><td>BMI (kg/m2):</td><td></td><td></td><td></td><td></td></tr><tr><td><25.0</td><td>34 (15.2)</td><td>177 (21.1)</td><td>1.0</td><td>1.0</td></tr><tr... |
6cfa12730dfab40348178bef705b36ebf56582472cc5b1bb4b4b3542e4dbacb2.png | complex | <table><tr><td><i>2008 Criteria for PMF</i></td><td><i>2016 Criteria for pre-PMF</i></td><td><i>2016 Criteria for overt PMF</i></td></tr><tr><td colspan="3"><i>Major criteria</i></td></tr><tr><td> MK proliferiferation and atypia with fibrosis (reticulin and/or collagen) or increased marrow cellularity, granulocytic pro... | <table><tr><td>2008 Criteria for PMF</td><td>2016 Criteria for pre-PMF</td><td>2016 Criteria for overt PMF</td></tr><tr><td colspan="3">Major criteria</td></tr></table> | <table><tr><td>MK proliferiferation and atypia with fibrosis (reticulin and/or collagen) or increased marrow cellularity, granulocytic proliferation and decreased erythropoesis in the absence of fibrosis</td><td>MK proliferation and atypia without reticulin fibrosis with increased marrow cellularity, granulocytic proli... |
b7cd63b4356aa4440bf75482076cad1a367d53fb868c2b341107532f8a4c4290.png | simple | <table><tr><td>Test Method</td><td>ASTM Standard</td><td>Dimension (<i>L</i> × <i>W</i> × <i>T</i>, mm<sup>3</sup>)</td><td>Calibrating Length (mm)</td></tr><tr><td>90°/0° tensile</td><td>D3039/D3039M-08</td><td>220 × 20 × 2.5</td><td>140</td></tr><tr><td>±45° tensile</td><td>D35... | <table><tr><td>Test Method</td></tr><tr><td>90°/0° tensile</td></tr><tr><td>±45° tensile</td></tr><tr><td>±45°/90°/0° compression</td></tr><tr><td>DCB</td></tr><tr><td>3ENF</td></tr><tr><td>Mode III</td></tr></table> | <table><tr><td>ASTM Standard</td><td>Dimension (L × W × T, mm3)</td><td>Calibrating Length (mm)</td></tr><tr><td>D3039/D3039M-08</td><td>220 × 20 × 2.5</td><td>140</td></tr><tr><td>D3518/D3518M-13</td><td>180 × 20 × 2.5</td><td>100</td></tr><tr><td>D3410/D3410M-95</td><td>160 × 20 × 2.5</td><td>80</td></tr><tr><td>D552... |
823739d04c344f61d5c75e745f3747f059a22961a185b3c9340876d04ef8dc3a.png | complex | <table><tr><td>Question</td><td>Responses</td><td>Frequency</td><td>%</td><td>Total/350</td><td>Recoding/Routing</td></tr><tr><td rowspan="8">A1. In which of the following is the property situated?</td><td>Centre of a large city</td><td>0</td><td>0.0</td><td rowspan="8">336</td><td rowspan="8"></td></tr><tr><td>Suburbs... | <table><tr><td>Question</td><td>Responses</td><td>Frequency</td><td>%</td><td>Total/350</td><td>Recoding/Routing</td></tr><tr><td rowspan="2">A1. In which of the following is the property situated?</td><td>Centre of a large city</td><td>0</td><td>0.0</td><td rowspan="2">336</td><td rowspan="2"></td></tr><tr><td>Suburbs... | <table><tr><td>Question</td><td>Responses</td><td>Frequency</td><td>%</td><td>Total/350</td><td>Recoding/Routing</td></tr><tr><td rowspan="6">A1. In which of the following is the property situated?</td><td>Large town or small city</td><td>76</td><td>21.7</td><td rowspan="6">336</td><td rowspan="6"></td></tr><tr><td>Sma... |
b690a6cf2ad9fa19487e4c330a6b4b7923345a1993fb0ec91de40970951409c4.png | complex | <table><tr><td>Variables</td><td>Total</td><td colspan="3">Progastrin staining in HP epithelial cells</td><td> </td></tr><tr><td> </td><td>N = 48</td><td>No/Low expression</td><td>Moderate expression</td><td>High expression</td><td>p-value</td></tr><tr><td> </td><td> </td><td>N = 21</td><td>N = 12</td><td>N = 15</td><t... | <table><tr><td>Variables</td><td>Total</td><td colspan="3">Progastrin staining in HP epithelial cells</td><td></td></tr><tr><td></td><td>N = 48</td><td>No/Low expression</td><td>Moderate expression</td><td>High expression</td><td>p-value</td></tr><tr><td></td><td></td><td>N = 21</td><td>N = 12</td><td>N = 15</td><td></... | <table><tr><td>Variables</td><td>Total</td><td colspan="3">Progastrin staining in HP epithelial cells</td><td></td></tr><tr><td></td><td>N = 48</td><td>No/Low expression</td><td>Moderate expression</td><td>High expression</td><td>p-value</td></tr><tr><td></td><td></td><td>N = 21</td><td>N = 12</td><td>N = 15</td><td></... |
43d6811c7d95c72547fd13130b03e83ad5116ecdc3b192f0e36076a81b6a3abf.png | simple | <table><tr><td>From</td><td>To</td><td>Rate (95% HPD)*</td><td>No. of Jumps (95% HPD)†</td><td>Jump proportion‡</td><td>BF§</td></tr><tr><td>Elk</td><td>Bison</td><td>0.59 (0.02–1.42)</td><td>5.24 (2.05–7.71)</td><td>0.021</td><td>110</td></tr><tr><td> </td><td>Livestock</td><td>1.68 (0.25&... | <table><tr><td>From</td><td>To</td><td>Rate (95% HPD)*</td><td>No. of Jumps (95% HPD)†</td><td>Jump proportion‡</td><td>BF§</td></tr><tr><td>Elk</td><td>Bison</td><td>0.59 (0.02–1.42)</td><td>5.24 (2.05–7.71)</td><td>0.021</td><td>110</td></tr><tr><td></td><td>Livestock</td><td>1.68 (0.25–3.46)</td><td>16.36 (14.23–19.... | <table><tr><td>From</td><td>To</td><td>Rate (95% HPD)*</td><td>No. of Jumps (95% HPD)†</td><td>Jump proportion‡</td><td>BF§</td></tr><tr><td></td><td>Livestock</td><td>0.33 (0.00–2.32)</td><td>0.00 (0.00–1.56)</td><td>0.002</td><td><3</td></tr><tr><td>Livestock</td><td>Bison</td><td>0.31 (0.00–2.30)</td><td>0.00 (0.00–... |
0d4a3e825d8e58f30db641532b6849c77e88c3ea22d8ad60eb6d561dcbecf2fe.png | simple | <table><tr><td>Adverse event</td><td>Estimated incidence</td></tr><tr><td>a) death</td><td>20%*</td></tr><tr><td>b) necrotising enterocolitis or focal intestinal perforation diagnosed on clinical grounds, or at surgery</td><td>15%*</td></tr><tr><td>c) intracranial abnormality (parenchymal haemorrhage or focal white mat... | <table><tr><td>Adverse event</td><td>Estimated incidence</td></tr><tr><td>a) death</td><td>20%*</td></tr><tr><td>b) necrotising enterocolitis or focal intestinal perforation diagnosed on clinical grounds, or at surgery</td><td>15%*</td></tr><tr><td>c) intracranial abnormality (parenchymal haemorrhage or focal white mat... | <table><tr><td>Adverse event</td><td>Estimated incidence</td></tr><tr><td>g) sustained tachycardia (greater than 220 beats per minute for more than 30 minutes in a 60 minute period)</td><td>20%**</td></tr><tr><td>h) pulmonary haemorrhage</td><td>5%**</td></tr><tr><td>i) persistent weight loss after 14 days after birth ... |
a48217a04c790661014d91b33b2a9768684495c48d8b75217f3ed17eb1c68448.png | complex | <table><tr><td></td><td colspan="3">PCr/ATP</td></tr><tr><td>Subject</td><td>MaxV</td><td>MaxV‐50V</td><td>Mean</td></tr><tr><td>1</td><td>1.96 ± 0.29</td><td>1.94 ± 0.43</td><td>1.95 ± 0.35</td></tr><tr><td>2</td><td>2.01 ± 0.37</td><td>1.85 ± 0.47</td><td>1.93 ± 0.38</td></tr><tr><... | <table><tr><td></td></tr><tr><td>Subject</td></tr><tr><td>1</td></tr><tr><td>2</td></tr><tr><td>3</td></tr><tr><td>4</td></tr><tr><td>5</td></tr><tr><td>6</td></tr><tr><td>7</td></tr><tr><td>8</td></tr><tr><td>9</td></tr><tr><td>Mean</td></tr></table> | <table><tr><td colspan="3">PCr/ATP</td></tr><tr><td>MaxV</td><td>MaxV‐50V</td><td>Mean</td></tr><tr><td>1.96 ± 0.29</td><td>1.94 ± 0.43</td><td>1.95 ± 0.35</td></tr><tr><td>2.01 ± 0.37</td><td>1.85 ± 0.47</td><td>1.93 ± 0.38</td></tr><tr><td>1.93 ± 0.37</td><td>2.08 ± 0.38</td><td>2.00 ± 0.30</td></tr><tr><td>2.27 ± 0.... |
e046430754189423d15266c734756dcab91d7ae569163838b5b84f998a567338.png | simple | <table><tr><td>Strain</td><td>Growth rate</td><td>masses</td><td>terminal phenotype</td></tr><tr><td>w1118</td><td>+++</td><td>-</td><td>viable</td></tr><tr><td>da-Gal4</td><td>+++</td><td>-</td><td>viable</td></tr><tr><td>tub-Gal4</td><td>+++</td><td>-</td><td>homozygous lethal</td></tr><tr><td>act5c-Gal4</td><td>+++<... | <table><tr><td>Strain</td><td>Growth rate</td></tr><tr><td>w1118</td><td>+++</td></tr><tr><td>da-Gal4</td><td>+++</td></tr><tr><td>tub-Gal4</td><td>+++</td></tr><tr><td>act5c-Gal4</td><td>+++</td></tr><tr><td>UAS-Dis3 (35090)</td><td>+++</td></tr><tr><td>UAS-Dis3 (35091)</td><td>+++</td></tr><tr><td>da-Gal4/UAS-Dis3 (3... | <table><tr><td>masses</td><td>terminal phenotype</td></tr><tr><td>-</td><td>viable</td></tr><tr><td>-</td><td>viable</td></tr><tr><td>-</td><td>homozygous lethal</td></tr><tr><td>-</td><td>homozygous lethal</td></tr><tr><td>-</td><td>viable</td></tr><tr><td>-</td><td>homozygous lethal</td></tr><tr><td>+</td><td>2nd ins... |
f5e7ca5fb7de687d5fc626bbddd6d4586e3e4b8728bec44799441e6a8bb6ba18.png | complex | <table><tr><td rowspan="2">Number</td><td colspan="3">Mixtures Composition (wt %)</td></tr><tr><td>Stellite 6</td><td>WS<sub>2</sub></td><td>NbC</td></tr><tr><td>Coating 1</td><td>100</td><td>-</td><td>-</td></tr><tr><td>Coating 2</td><td>85</td><td>15</td><td>-</td></tr><tr><td>Coating 3</td><td>70</td><td>-</td><td>3... | <table><tr><td rowspan="2">Number</td><td colspan="3">Mixtures Composition (wt %)</td></tr><tr><td>Stellite 6</td><td>WS2</td><td>NbC</td></tr><tr><td>Coating 1</td><td>100</td><td>-</td><td>-</td></tr><tr><td>Coating 2</td><td>85</td><td>15</td><td>-</td></tr><tr><td>Coating 3</td><td>70</td><td>-</td><td>30</td></tr>... | <table><tr><td rowspan="2">Number</td><td colspan="3">Mixtures Composition (wt %)</td></tr><tr><td>Stellite 6</td><td>WS2</td><td>NbC</td></tr><tr><td>Coating 5</td><td>55</td><td>15</td><td>30</td></tr><tr><td>Coating 6</td><td>50</td><td>20</td><td>30</td></tr></table> |
58b5ca22ceea3518f88a8a46ca191b0e43361759aea2a848d64f53f7cc4f4743.png | complex | <table><tr><td rowspan="2">Region</td><td rowspan="2">R/L/M</td><td rowspan="2">BA</td><td colspan="3">MNI coordinate</td><td colspan="2">Stats</td></tr><tr><td><i>x</i></td><td><i>y</i></td><td><i>z</i></td><td><i>T</i></td><td>Size<sup>a</sup></td></tr><tr><td colspan="8">Group difference</td></tr><tr><td>IGO < Co... | <table><tr><td rowspan="2">Region</td><td rowspan="2">R/L/M</td><td rowspan="2">BA</td><td colspan="3">MNI coordinate</td><td colspan="2">Stats</td></tr><tr><td>x</td><td>y</td><td>z</td><td>T</td><td>Sizea</td></tr><tr><td colspan="8">Group difference</td></tr><tr><td>IGO < Control</td><td></td><td></td><td></td><td><... | <table><tr><td rowspan="2">Region</td><td rowspan="2">R/L/M</td><td rowspan="2">BA</td><td colspan="3">MNI coordinate</td><td colspan="2">Stats</td></tr><tr><td>x</td><td>y</td><td>z</td><td>T</td><td>Sizea</td></tr><tr><td>mOFC/vmPFC</td><td>M</td><td>11</td><td>−2</td><td>44</td><td>−10</td><td>19.8</td><td>24</td></... |
ac6191089fac3998fd6326bce833aa4d9fe17a35a301ec26e7fea940767aeb74.png | simple | <table><tr><td>Characteristics</td><td>Group-1 (n = 53) No SG</td><td>Group-2 (n = 27) Mild SG</td><td>Group-3 (n = 65) Severe SG</td><td><i>p</i>-value</td></tr><tr><td>Age (years)</td><td>31 (27-34)</td><td>27 (25-29)</td><td>28 (24-30)</td><td>0.001</td></tr><tr><td>Gravidity (2 / 3 / 4 / >4)</td><td>40/10/3/0</t... | <table><tr><td>Characteristics</td><td>Group-1 (n = 53) No SG</td><td>Group-2 (n = 27) Mild SG</td><td>Group-3 (n = 65) Severe SG</td><td>p-value</td></tr><tr><td>Age (years)</td><td>31 (27-34)</td><td>27 (25-29)</td><td>28 (24-30)</td><td>0.001</td></tr><tr><td>Gravidity (2 / 3 / 4 / >4)</td><td>40/10/3/0</td><td>20/6... | <table><tr><td>Characteristics</td><td>Group-1 (n = 53) No SG</td><td>Group-2 (n = 27) Mild SG</td><td>Group-3 (n = 65) Severe SG</td><td>p-value</td></tr><tr><td>t C/S</td><td>38.42±1.08</td><td>.88</td><td>±0.67</td><td></td></tr><tr><td>Birth weight of second baby (gram)</td><td>3315±297</td><td>3270±458</td><td>335... |
709f50f80b585151f2837f61ab789c5573898f40ab82846b0f73210c8fc380e3.png | complex | <table><tr><td rowspan="2">Pregnancy and Neonatal Outcomes</td><td colspan="4">Cobalt (μg/L)</td><td colspan="4">Copper (μg/dL)</td><td colspan="4">Zinc (μg/dL)</td><td colspan="4">Selenium (μg/L)</td></tr><tr><td>High (<i>n</i> = 9)</td><td>Not High (<i>n</i> = 236)</td><td><i>p</i><sup>a</sup></td... | <table><tr><td rowspan="2">Pregnancy and Neonatal Outcomes</td><td colspan="2">Cobalt (μg/L)</td></tr><tr><td>High (n = 9)</td><td>Not High (n = 236)</td></tr><tr><td>Gestational diabetes, n (%)</td><td>0 (0)</td><td>18 (7.6)</td></tr><tr><td>Preeclampsia, n (%)</td><td>0 (0)</td><td>5 (2.1)</td></tr><tr><td>Gestationa... | <table><tr><td colspan="2">Cobalt (μg/L)</td><td colspan="4">Copper (μg/dL)</td><td colspan="4">Zinc (μg/dL)</td><td colspan="4">Selenium (μg/L)</td></tr><tr><td>pa</td><td>pb</td><td>High (n = 172)</td><td>Not High (n = 73)</td><td>pa</td><td>pb</td><td>Low (n = 187)</td><td>Not Low (n = 58)</td><td>pa</td><td>pb</td>... |
d8fc6a1591e0b3eae9086ba6f4a466bbe42ef0f92b8130e1b667a22441708606.png | complex | <table><tr><td></td><td colspan="3">All synolog pairs</td><td colspan="3">≥90% protein sequence identity between synolog pairs</td></tr><tr><td></td><td>Median ± MAD</td><td>Min</td><td>Max</td><td>Median ± MAD</td><td>Min</td><td>Max</td></tr><tr><td>Number of carbohydrate metabolism synologs</td><td>4... | <table><tr><td></td><td colspan="3">All synolog pairs</td><td>≥90% protein sequence identity between synolog pairs</td></tr><tr><td></td><td>Median ± MAD</td><td>Min</td><td>Max</td><td>Median ± MAD</td></tr><tr><td>Number of carbohydrate metabolism synologs</td><td>49.0 ± 35.0</td><td>0</td><td>394</td><td>0.0 ± 0.0</... | <table><tr><td colspan="2">≥90% protein sequence identity between synolog pairs</td></tr><tr><td>Min</td><td>Max</td></tr><tr><td>0</td><td>47</td></tr><tr><td>0</td><td>16</td></tr><tr><td>90.0</td><td>100.0</td></tr><tr><td>0.0</td><td>34.6</td></tr></table> |
771767437f360c6fb4f1bc3ab92b0498f04a7cf9383342556ee221e90579d311.png | complex | <table><tr><td>Source</td><td>Variable</td><td># Items</td><td>Response options</td><td>Cronbach’s α</td><td>Pearson’s <i>r</i></td><td>Potential Range</td><td>Actual Range</td><td>Mean (SD)</td></tr><tr><td></td><td colspan="8">Social Support for Healthy Eating</td></tr><tr><td>Child</td><td>Family Fo... | <table><tr><td>Source</td><td>Variable</td><td># Items</td><td>Response options</td><td>Cronbach’s α</td><td>Pearson’s r</td><td>Potential Range</td><td>Actual Range</td><td>Mean (SD)</td></tr><tr><td></td><td colspan="8">Social Support for Healthy Eating</td></tr><tr><td>Child</td><td>Family Food Culture</td><td>4</td... | <table><tr><td>Source</td><td>Variable</td><td># Items</td><td>Response options</td><td>Cronbach’s α</td><td>Pearson’s r</td><td>Potential Range</td><td>Actual Range</td><td>Mean (SD)</td></tr><tr><td></td><td colspan="8">cial Support for Physical Activity</td></tr><tr><td>Parent</td><td>Instrumental support for PA</td... |
962edad74c58bfeecfd1f1083b0c7e7bd1b4e7cae7c930e930c0987edefba161.png | complex | <table><tr><td colspan="5">FACTOR1</td></tr><tr><td>GO ID</td><td>GO Term</td><td>Size</td><td>Count</td><td>Pvalue</td></tr><tr><td>GO.0007051</td><td>spindle organization</td><td>6</td><td>2</td><td>8.20E-03</td></tr><tr><td>GO.0050931</td><td>pigment cell differentiation</td><td>7</td><td>2</td><td>0.011</td></tr><t... | <table><tr><td colspan="5">FACTOR1</td></tr><tr><td>GO ID</td><td>GO Term</td><td>Size</td><td>Count</td><td>Pvalue</td></tr><tr><td>GO.0007051</td><td>spindle organization</td><td>6</td><td>2</td><td>8.20E-03</td></tr><tr><td>GO.0050931</td><td>pigment cell differentiation</td><td>7</td><td>2</td><td>0.011</td></tr><t... | <table><tr><td colspan="5">FACTOR1</td></tr><tr><td>GO.0016570</td><td>histone modification</td><td>13</td><td>2</td><td>0.038</td></tr><tr><td>GO.0015698</td><td>inorganic anion transport</td><td>53</td><td>4</td><td>0.039</td></tr><tr><td>GO.0007156</td><td>homophilic cell adhesion</td><td>32</td><td>3</td><td>0.041<... |
7da1f135f939b2e3b3566b8d865a19ee8b7a64bda94ec696b3730422cd7fe549.png | complex | <table><tr><td>Complication</td><td>Incidence [25]</td><td>Cost for treatment</td></tr><tr><td rowspan="2">Re-operation (any reason) (including infection)</td><td rowspan="2">0.30% (3 out of 1,000)</td><td>- CPT 29871 (surgical, for infection, lavage and drainage); $521.91</td></tr><tr><td>- APC 0041(knee arthroscopy/d... | <table><tr><td>Complication</td><td>Incidence [25]</td><td>Cost for treatment</td></tr><tr><td rowspan="2">Re-operation (any reason) (including infection)</td><td rowspan="2">0.30% (3 out of 1,000)</td><td>- CPT 29871 (surgical, for infection, lavage and drainage); $521.91</td></tr><tr><td>- APC 0041(knee arthroscopy/d... | <table><tr><td>Venous thromboembolism (VTE)</td><td>0.19% (1.9 out of 1,000)</td><td>Costs over a 12 month timeframe for treating VTE; $14,865</td></tr><tr><td>Deep vein thrombosis (DVT)</td><td>0.12% (1.2 out of 1,000)</td><td>Costs over a 12 month timeframe for treating DVT [43]; $14,865</td></tr><tr><td>Pulmonary em... |
0d6e5f1f1b376ca4087c2165e43002fa0d9643bf2429d51c3c8e0602951da007.png | complex | <table><tr><td rowspan="2">Markers</td><td rowspan="2">Chromosome</td><td rowspan="2">Position (bp)</td><td colspan="4">Number of individuals</td></tr><tr><td>a</td><td>h</td><td>b</td><td>Total</td></tr><tr><td>mSI_26</td><td>CH1</td><td>3 377 732</td><td>5</td><td>228</td><td>118</td><td>351</td></tr><tr><td>mSI_88</... | <table><tr><td rowspan="2">Markers</td><td rowspan="2">Chromosome</td><td rowspan="2">Position (bp)</td><td colspan="4">Number of individuals</td></tr><tr><td>a</td><td>h</td><td>b</td><td>Total</td></tr><tr><td>mSI_26</td><td>CH1</td><td>3 377 732</td><td>5</td><td>228</td><td>118</td><td>351</td></tr><tr><td>mSI_88</... | <table><tr><td rowspan="2">Markers</td><td rowspan="2">Chromosome</td><td rowspan="2">Position (bp)</td><td colspan="4">Number of individuals</td></tr><tr><td>a</td><td>h</td><td>b</td><td>Total</td></tr><tr><td>mSI_113</td><td>CH1</td><td>4 252 975</td><td>6</td><td>284</td><td>172</td><td>456</td></tr><tr><td>mSI_462... |
c13b2e5336325446ae686fc870a1a0770ab4aca61430d0a2ccbdca738f6278dc.png | simple | <table><tr><td>Location</td><td>PT-INR tests</td><td>Range stated</td><td>Cause stated</td></tr><tr><td>PHCC Östergötland</td><td>499</td><td>480</td><td>495</td></tr><tr><td>PHCC Eksjö</td><td>65</td><td>65</td><td>65</td></tr><tr><td>PHCC total (men/women)</td><td>564 (289/275)</td><td>545 (282/263)... | <table><tr><td>Location</td><td>PT-INR tests</td><td>Range stated</td><td>Cause stated</td></tr><tr><td>PHCC Östergötland</td><td>499</td><td>480</td><td>495</td></tr><tr><td>PHCC Eksjö</td><td>65</td><td>65</td><td>65</td></tr><tr><td>PHCC total (men/women)</td><td>564 (289/275)</td><td>545 (282/263)</td><td>560 (2... | <table><tr><td>ACC Total (men/women)</td><td>927 (540/387)</td><td>927 (540/387)</td><td>915 (531/384)</td></tr></table> |
4de7c341ed7b06322765c0fa055972cc198e37baa3f1c76e431c02d53b63b90e.png | complex | <table><tr><td>Parameters</td><td>Cases ± SD</td><td>Controls ± SD</td><td><i>p</i> value</td></tr><tr><td>Total SOD Activity (U/ml)</td><td>285.44 ± 114.36</td><td>319.79 ± 126.12</td><td>0.144</td></tr><tr><td>SOD Activity (U/ml) of cases on Metformin only<sup><i>a</i></sup></td><td>274.81 ± ... | <table><tr><td>Parameters</td><td>Cases ± SD</td><td>Controls ± SD</td></tr><tr><td>Total SOD Activity (U/ml)</td><td>285.44 ± 114.36</td><td>319.79 ± 126.12</td></tr><tr><td>SOD Activity (U/ml) of cases on Metformin onlya</td><td>274.81 ± 122.73</td><td>-</td></tr><tr><td>SOD Activity (U/ml) of cases on Metformin and ... | <table><tr><td>p value</td></tr><tr><td>0.144</td></tr><tr><td>a*b*c =0.771</td></tr><tr><td>Post hoc:</td></tr><tr><td>a*b =0.824 ;</td></tr><tr><td>a*c =0.499;</td></tr><tr><td>b*c =0.5265</td></tr></table> |
7fccce226e76b4ac28a9167c8ab592ce4f6f92e88b7ab4bc23491edf88da8e2f.png | simple | <table><tr><td>Group</td><td>A</td><td>B</td><td>C</td><td>D</td></tr><tr><td>Parameters</td><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td></tr><tr><td>Normal Morphology</td><td>97.44 ± 0.94</td><td>91.09 ± 2.91***</td><td>91.60 ± 3.37***</td><td>94.56 ±... | <table><tr><td>Group</td></tr><tr><td>Parameters</td></tr><tr><td>Normal Morphology</td></tr><tr><td>Abnormal Head</td></tr><tr><td>Abnormal Tail</td></tr></table> | <table><tr><td>A</td><td>B</td><td>C</td><td>D</td></tr><tr><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td><td>Mean ± SD</td></tr><tr><td>97.44 ± 0.94</td><td>91.09 ± 2.91***</td><td>91.60 ± 3.37***</td><td>94.56 ± 1.12***</td></tr><tr><td>1.74 ± 0.69</td><td>3.87 ± 1.64**</td><td>3.73 ± 2.49*</td><td>1.84 ± 0.6... |
8905a86c90ba99e696f371a0acc2104fc7a64431eeb1fed85326ad98d18c9620.png | complex | <table><tr><td></td><td colspan="2">Derivation set (<i>N</i> = 38)</td><td><i>P</i>-value (Wilcoxon)</td></tr><tr><td></td><td>No response (<i>N</i> = 21)</td><td>Response (<i>N</i> = 16)</td><td></td></tr><tr><td>miR375</td></tr><tr><td>Mean ± STD</td><td>5.2 ± 2.2</td><td>7.1 ± 1.8</td><td>0.01</td></t... | <table><tr><td></td><td colspan="2">Derivation set (N = 38)</td><td>P-value (Wilcoxon)</td></tr><tr><td></td><td>No response (N = 21)</td><td>Response (N = 16)</td><td></td></tr><tr><td>miR375</td><td colspan="3"></td></tr><tr><td>Mean ± STD</td><td>5.2 ± 2.2</td><td>7.1 ± 1.8</td><td>0.01</td></tr></table> | <table><tr><td></td><td colspan="2">Derivation set (N = 38)</td><td>P-value (Wilcoxon)</td></tr><tr><td></td><td>No response (N = 21)</td><td>Response (N = 16)</td><td></td></tr><tr><td>Median (min–max)</td><td>5.8 (−0.5–7.9)</td><td>7.3 (4.2–9.8)</td><td></td></tr><tr><td>miR149</td><td colspan="3"></td></tr><tr><td>M... |
fdf60ced0717b9d4a17d64cf0952f6807e9ca004a4050678f67d6567fcf2f23e.png | simple | <table><tr><td>Variant</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr><tr><td>Length (bp)</td><td>1536</td><td>1425</td><td>1419</td><td>1425</td><td>1230</td><td>1326</td><td>1188</td><td>1425</td></tr><tr><td><i>M </i>(%)</td><td>94</td><td>99</td><td>96</td><td>99</td><td>98... | <table><tr><td>Variant</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr></table> | <table><tr><td>Length (bp)</td><td>1536</td><td>1425</td><td>1419</td><td>1425</td><td>1230</td><td>1326</td><td>1188</td><td>1425</td></tr><tr><td>M (%)</td><td>94</td><td>99</td><td>96</td><td>99</td><td>98</td><td>99</td><td>98</td><td>100</td></tr><tr><td>m (%)</td><td>54</td><td>51</td><td>64</td><td>76</td><td>54... |
9b6efedca42e2efe9716c185f0aff3d54fe36284a26ce8b441ab579ba86e3ac4.png | complex | <table><tr><td>Type of analysis</td><td>HR</td><td>SE</td><td>95% CI</td><td>P-value</td></tr><tr><td colspan="5">VTE risk</td></tr><tr><td>Crude analysis</td><td>0.66</td><td>0.29</td><td>(0.28-1.54)</td><td>0.33</td></tr><tr><td>PS stratified analysis*</td><td>0.63</td><td>0.29</td><td>(0.25-1.57)</td><td>0.33</td></... | <table><tr><td>Type of analysis</td><td>HR</td><td>SE</td><td>95% CI</td><td>P-value</td></tr><tr><td colspan="5">VTE risk</td></tr><tr><td>Crude analysis</td><td>0.66</td><td>0.29</td><td>(0.28-1.54)</td><td>0.33</td></tr><tr><td>PS stratified analysis*</td><td>0.63</td><td>0.29</td><td>(0.25-1.57)</td><td>0.33</td></... | <table><tr><td>Type of analysis</td><td>HR</td><td>SE</td><td>95% CI</td><td>P-value</td></tr><tr><td colspan="5">Hospital Mortality</td></tr><tr><td>Crude analysis</td><td>1.26</td><td>0.18</td><td>(0.95-1.68)</td><td>0.10</td></tr><tr><td>PS stratified analysis*</td><td>0.98</td><td>0.16</td><td>(0.72-1.36)</td><td>0... |
53f19bdb51e49eaef25ab55ce53ea61b38595a872c6c29489bcc8aa12743d844.png | complex | <table><tr><td></td><td colspan="2">Mating systems</td><td>Promiscuity</td></tr><tr><td colspan="4">Humans included in the model</td></tr><tr><td>Relative brain size</td><td><i>F</i> = 6.59</td><td><i>p</i> = 0.002</td><td><i>p</i> = 0.570</td></tr><tr><td>Relative testis size</td><td><i>F</i> = 26.93</td><td><i>p</i>&... | <table><tr><td></td><td colspan="2">Mating systems</td><td>Promiscuity</td></tr></table> | <table><tr><td colspan="4">Humans included in the model</td></tr><tr><td>Relative brain size</td><td>F = 6.59</td><td>p = 0.002</td><td>p = 0.570</td></tr><tr><td>Relative testis size</td><td>F = 26.93</td><td>p<0.0001</td><td>p<0.0001</td></tr><tr><td>Sexual dimorphism</td><td>F = 3.83</td><td>p = 0.021</td><td>p = 0.... |
059990f915dfb877741b3b385a9d6d5fcb64fa573e089a7857b6a89ae6ee7a53.png | complex | <table><tr><td> </td><td colspan="2">First-born children born in 2008</td><td colspan="2">The 2008 birth cohort</td><td colspan="2">The 2006 birth cohort*</td></tr><tr><td> </td><td>Total <i>n</i></td><td>%</td><td>Total <i>n</i></td><td>%</td><td>Total <i>n</i></td><td>%</td></tr><tr><td>MS score negative (=0)</td><td... | <table><tr><td></td><td colspan="2">First-born children born in 2008</td><td colspan="2">The 2008 birth cohort</td><td colspan="2">The 2006 birth cohort*</td></tr><tr><td></td><td>Total n</td><td>%</td><td>Total n</td><td>%</td><td>Total n</td><td>%</td></tr><tr><td>MS score negative (=0)</td><td>617</td><td>91</td><td... | <table><tr><td>Control group</td><td>199</td><td>92</td><td>449</td><td>93</td><td>305</td><td>86</td></tr><tr><td>P</td><td></td><td>0.658</td><td></td><td>0.011</td><td></td><td>0.129</td></tr></table> |
569bb3f4772de0f287ccca5af315319a356b06f6c727d74dc9ba32ffccac3040.png | simple | <table><tr><td>Transcript support</td><td>5' end</td><td>3' end</td></tr><tr><td>FANTOM3</td><td>3,211</td><td>3,211</td></tr><tr><td>PUBLIC</td><td>2,666</td><td>2,666</td></tr><tr><td>5' ESTs</td><td>20,866</td><td>-</td></tr><tr><td>3' ESTs</td><td>-</td><td>32,166</td></tr><tr><td>Public ESTs</td><td>41,543</td><td... | <table><tr><td>Transcript support</td><td>5' end</td><td>3' end</td></tr><tr><td>FANTOM3</td><td>3,211</td><td>3,211</td></tr><tr><td>PUBLIC</td><td>2,666</td><td>2,666</td></tr><tr><td>5' ESTs</td><td>20,866</td><td>-</td></tr><tr><td>3' ESTs</td><td>-</td><td>32,166</td></tr><tr><td>Public ESTs</td><td>41,543</td><td... | <table><tr><td>SC</td><td>616</td><td>,616</td></tr><tr><td>CAGE</td><td>162,707</td><td>-</td></tr><tr><td>Total count</td><td>259,888</td><td>82,927</td></tr></table> |
0183110170c067ef5891bb378274202272d0832714fa66746e5826848dead43a.png | complex | <table><tr><td rowspan="2">Type of drug related questions</td><td colspan="3">Response <i>N</i> (%)</td></tr><tr><td>Never</td><td>Sometimes</td><td>Always</td></tr><tr><td>Price</td><td>5 (10.4)</td><td>14 (29.2)</td><td>29 (60.4)</td></tr><tr><td>Dosage</td><td>0</td><td>27 (56.2)</td><td>21 (43.8)</td></tr><tr><td>D... | <table><tr><td rowspan="2">Type of drug related questions</td><td colspan="3">Response N (%)</td></tr><tr><td>Never</td><td>Sometimes</td><td>Always</td></tr></table> | <table><tr><td>Price</td><td>5 (10.4)</td><td>14 (29.2)</td><td>29 (60.4)</td></tr><tr><td>Dosage</td><td>0</td><td>27 (56.2)</td><td>21 (43.8)</td></tr><tr><td>Drug identification</td><td>2 (4.2)</td><td>32 (66.7)</td><td>14 (29.1)</td></tr><tr><td>Efficacy of drugs</td><td>8 (16.6)</td><td>27 (56.3)</td><td>13 (27.1)... |
66ccaed42eb251d283d1fd6b4c7acf5e44b7361c87cd3fe9b1f95bba588c14ac.png | complex | <table><tr><td></td><td colspan="4">Non-injection drug users</td><td colspan="4">Injection drug users</td></tr><tr><td></td><td><i>Total</i></td><td><i>Current IM use</i></td><td><i>No current IM use</i></td><td></td><td><i>Total</i></td><td><i>Current IM use</i></td><td><i>No current IM use</i></td><td></td></tr><tr><... | <table><tr><td></td><td colspan="4">Non-injection drug users</td><td colspan="4">Injection drug users</td></tr><tr><td></td><td>Total</td><td>Current IM use</td><td>No current IM use</td><td></td><td>Total</td><td>Current IM use</td><td>No current IM use</td><td></td></tr><tr><td></td><td>n = 955</td><td>n = 113</td><t... | <table><tr><td>der</td><td> (0.2)</td><td>(0)</td><td>2)</td><td>1.000b</td><td>(0.4)</td><td> (1.3)</td><td>)</td><td>120b</td></tr><tr><td>Race</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Hispanic</td><td>430 (45.0)</td><td>67 (59.3)</td><td>363 (43.1)</td><td>0.001</td><t... |
e3985ff5df60d1cc170c10569f4300f94b5bc3f301c64243eff88f5346ec6aaf.png | complex | <table><tr><td>Variables</td><td>Stroke <i>n</i> = 358</td><td>Non-stroke <i>n</i> = 58</td><td><i>P</i></td></tr><tr><td>Age</td><td>69.2 ± 13.8</td><td>70.6 ± 11.4</td><td>0.397</td></tr><tr><td>Male, <i>n</i> (%)</td><td>210 (58.7)</td><td>37 (63.8)</td><td>0.460</td></tr><tr><td>SBP, mmHg</td><td>168.8 &#... | <table><tr><td>Variables</td><td>Stroke n = 358</td><td>Non-stroke n = 58</td><td>P</td></tr><tr><td>Age</td><td>69.2 ± 13.8</td><td>70.6 ± 11.4</td><td>0.397</td></tr><tr><td>Male, n (%)</td><td>210 (58.7)</td><td>37 (63.8)</td><td>0.460</td></tr><tr><td>SBP, mmHg</td><td>168.8 ± 31.9</td><td>147.8 ± 27.6</td><td><0.0... | <table><tr><td>GCS ≤ 8, n (%)</td><td>61 (17)</td><td>2 (3.4)</td><td>0.007*</td></tr><tr><td>GCS, median (IQR)</td><td>15 (12–15)</td><td>15 (15–15)</td><td><0.001*</td></tr></table> |
c84d13aa2a0399d8453886fc7ba12267d6ec5bdcad6ea83b585195536dcfc0f1.png | complex | <table><tr><td>Primer</td><td>Sequence</td></tr><tr><td rowspan="2">miR-182</td><td>F: 5′-GGCAATGGTAGAACTCACACT-3′</td></tr><tr><td>R: 5′-AACATGTACAGTCCATGGATG-3′</td></tr><tr><td rowspan="2">HOXA9</td><td>F: 5′-TGCCCTCCAGCCGGCCTTAT-3′</td></tr><tr><td>R: 5′-CCGCTTTGTGCGGGGATGG... | <table><tr><td>Primer</td></tr><tr><td rowspan="2">miR-182</td></tr><tr></tr><tr><td rowspan="2">HOXA9</td></tr><tr></tr><tr><td rowspan="2">Wnt</td></tr><tr></tr><tr><td rowspan="2">CTNNB1</td></tr><tr></tr><tr><td rowspan="2">WIF-1</td></tr><tr></tr><tr><td rowspan="2">Survivin</td></tr><tr></tr><tr><td rowspan="2">C... | <table><tr><td>Sequence</td></tr><tr><td>F: 5′-GGCAATGGTAGAACTCACACT-3′</td></tr><tr><td>R: 5′-AACATGTACAGTCCATGGATG-3′</td></tr><tr><td>F: 5′-TGCCCTCCAGCCGGCCTTAT-3′</td></tr><tr><td>R: 5′-CCGCTTTGTGCGGGGATGGT-3</td></tr><tr><td>F: 5′-GCTAGCGAAAGTCATTGGC -3′</td></tr><tr><td>R: 5′-CATTGCATCGAAGTCGTG-3′</td></tr><tr><t... |
59f6ea98b689ee289aa254ce3907a440044f520a91f41fc32dee53825c855385.png | simple | <table><tr><td>Subgroup (Number of studies)</td><td></td><td>Summary DOR (95% CI)</td></tr><tr><td>Study design</td><td>Case-control (24)</td><td>134.4 (65.2 – 213.1)</td></tr><tr><td></td><td>Cross-sectional (60)</td><td>171.1 (106.7 – 274.2)</td></tr><tr><td>Blinding</td><td>Single or double blinded (29)<... | <table><tr><td>Subgroup (Number of studies)</td><td></td><td>Summary DOR (95% CI)</td></tr><tr><td>Study design</td><td>Case-control (24)</td><td>134.4 (65.2 – 213.1)</td></tr><tr><td></td><td>Cross-sectional (60)</td><td>171.1 (106.7 – 274.2)</td></tr><tr><td>Blinding</td><td>Single or double blinded (29)</td><td>90.2... | <table><tr><td>Subgroup (Number of studies)</td><td></td><td>Summary DOR (95% CI)</td></tr><tr><td>equence</td><td></td><td>4.6)</td></tr><tr><td></td><td>Other target (30)</td><td>77.4 (38.2 – 156.9)</td></tr><tr><td>Detection method</td><td>Probe (49)</td><td>130.6 (78.4 – 217.6)</td></tr><tr><td></td><td>Gel-UV (35)... |
fd8f46c2ad9eb615f9510a3c9c4e8919eae7dc19192006b6624841e0ea26fad4.png | complex | <table><tr><td rowspan="2">Region</td><td colspan="3">Value added of export spillover (100 million yuan)<sup>a</sup></td><td colspan="3">Proportion of export spillover<sup>b</sup> (%)</td></tr><tr><td>1997</td><td>2002</td><td>2007</td><td>1997</td><td>2002</td><td>2007</td></tr><tr><td colspan="7"><i>Eastern provinces... | <table><tr><td rowspan="2">Region</td><td colspan="3">Value added of export spillover (100 million yuan)a</td><td colspan="3">Proportion of export spilloverb (%)</td></tr><tr><td>1997</td><td>2002</td><td>2007</td><td>1997</td><td>2002</td><td>2007</td></tr><tr><td colspan="7">Eastern provinces</td></tr><tr><td>Beijing... | <table><tr><td>Tianjin</td><td>136</td><td>306</td><td>858</td><td>39</td><td>40</td><td>48</td></tr><tr><td>Hebei</td><td>77</td><td>115</td><td>562</td><td>33</td><td>34</td><td>45</td></tr><tr><td>Shanghai</td><td>334</td><td>518</td><td>2234</td><td>31</td><td>24</td><td>34</td></tr><tr><td>Jiangsu</td><td>340</td>... |
d50b5112afd96b229fd7aa1894517f6ff62601acb88cea6b4a5c6146bb2d9f8c.png | simple | <table><tr><td>Nanoparticle (NP)</td><td>Size of NP (nm)</td><td>Ligand/receptor</td><td>Drug/agent</td><td>Method to trace NP/drug/agent</td><td>Ref.</td></tr><tr><td>Polymer</td><td>70</td><td>Protein/TfR</td><td>siRNA</td><td>PCR</td><td>[236]</td></tr><tr><td>Liposome</td><td>ns</td><td>Ab/TfR</td><td>p53</td><td>p... | <table><tr><td>Nanoparticle (NP)</td><td>Size of NP (nm)</td><td>Ligand/receptor</td><td>Drug/agent</td><td>Method to trace NP/drug/agent</td><td>Ref.</td></tr><tr><td></td><td>7</td><td>Protein/</td><td>siRN</td><td>PCR</td><td>[23</td></tr></table> | <table><tr><td>Polymer</td><td>0</td><td>TfR</td><td>A</td><td></td><td>6]</td></tr><tr><td>Liposome</td><td>ns</td><td>Ab/TfR</td><td>p53</td><td>p53 via PCR</td><td>[271]</td></tr></table> |
1fdf5cc02e2cd63dcbed47cf782aee47cd443d285d8527febf52698b517f2b9b.png | simple | <table><tr><td>No of patients</td><td>61</td></tr><tr><td>No of CTCs</td><td>1262</td></tr><tr><td>Age</td><td></td></tr><tr><td>Median (range)</td><td>62 (23–82)</td></tr><tr><td></td><td>N (%)</td></tr><tr><td>Menopausal status</td><td></td></tr><tr><td>Pre</td><td>17 (27.9)</td></tr><tr><td>Post</td><td>41 (67... | <table><tr><td>No of patients</td><td>61</td></tr><tr><td>No of CTCs</td><td>1262</td></tr></table> | <table><tr><td>Age</td><td></td></tr><tr><td>Median (range)</td><td>62 (23–82)</td></tr><tr><td></td><td>N (%)</td></tr><tr><td>Menopausal status</td><td></td></tr><tr><td>Pre</td><td>17 (27.9)</td></tr><tr><td>Post</td><td>41 (67.2)</td></tr><tr><td>UN</td><td>3 (4.9)</td></tr><tr><td>ER</td><td></td></tr><tr><td>Posi... |
518bfe87f3e91e5326787751b52c0bf3265c0e144f62e579ac88ec1d0c4dd822.png | simple | <table><tr><td><i>V. albo</i>-<i>atrum</i></td><td><i>V. longisporum</i></td><td><i>V. dahliae</i></td><td><i>V. tricorpus</i></td></tr><tr><td>234</td><td>Bob-7</td><td>2341</td><td>2933</td></tr><tr><td>CBS-8</td><td>Vd-1</td><td>330</td><td>2901 A</td></tr><tr><td>CBS-7</td><td>43-3</td><td>G12-1</td><td>CBS-12</td>... | <table><tr><td>V. albo-atrum</td><td>V. longisporum</td></tr><tr><td>234</td><td>Bob-7</td></tr><tr><td>CBS-8</td><td>Vd-1</td></tr><tr><td>CBS-7</td><td>43-3</td></tr><tr><td>2934</td><td>Vd-11</td></tr><tr><td></td><td></td></tr></table> | <table><tr><td>V. dahliae</td><td>V. tricorpus</td></tr><tr><td>2341</td><td>2933</td></tr><tr><td>330</td><td>2901 A</td></tr><tr><td>G12-1</td><td>CBS-12</td></tr><tr><td>Vd-7</td><td>1901</td></tr><tr><td>G12-2</td><td></td></tr></table> |
f543e49c5456183e74dade077398df80164a534b76f7371ce58af83be5e1b197.png | complex | <table><tr><td>Factor</td><td>Category</td><td>Attendees</td><td>Non-attendees</td><td>OR (95 % CI)</td><td>OR (95 % CI)</td><td>OR (95 % CI)</td></tr><tr><td></td><td></td><td><i>N</i> (%)</td><td><i>N</i> (%)</td><td>Crude</td><td>Age-adjusted</td><td>Adjusted<sup>a</sup></td></tr><tr><td rowspan="3">Cancer in family... | <table><tr><td>Factor</td><td>Category</td><td>Attendees</td><td>Non-attendees</td><td>OR (95 % CI)</td><td>OR (95 % CI)</td><td>OR (95 % CI)</td></tr><tr><td></td><td></td><td>N (%)</td><td>N (%)</td><td>Crude</td><td>Age-adjusted</td><td>Adjusteda</td></tr><tr><td rowspan="3">Cancer in family</td><td>No</td><td>647 (... | <table><tr><td rowspan="2">Have had breast cancer</td><td>Yes</td><td>104 (7.8)</td><td>4 (3.2)</td><td>0.39 (0.14–1.08)</td><td>0.40 (0.14–1.10)</td><td>0.41 (0.15–1.15)</td></tr><tr><td>Missing</td><td>0</td><td>0</td><td>–</td><td>–</td><td>–</td></tr></table> |
bbb77184b6e62b058840928c3e629725e33cf851d8959a7091e9b1bc80c88b5b.png | complex | <table><tr><td> </td><td colspan="7"><i>Percentage of cell positive for MHC class II</i></td></tr><tr><td><i>MSCs: horse (ELA haplotype; age)</i></td><td>P2</td><td>P3</td><td>P4</td><td>P5</td><td>P6</td><td>P7</td><td>P8</td></tr><tr><td>1 (A3; 20 years)</td><td>58.36</td><td>54.67</td><td>63.07</td><td>53.54</td><td... | <table><tr><td></td><td colspan="7">Percentage of cell positive for MHC class II</td></tr><tr><td>MSCs: horse (ELA haplotype; age)</td><td>P2</td><td>P3</td><td>P4</td><td>P5</td><td>P6</td><td>P7</td><td>P8</td></tr><tr><td>1 (A3; 20 years)</td><td>58.36</td><td>54.67</td><td>63.07</td><td>53.54</td><td>46.22</td><td>... | <table><tr><td></td><td colspan="7">Percentage of cell positive for MHC class II</td></tr><tr><td>MSCs: horse (ELA haplotype; age)</td><td>P2</td><td>P3</td><td>P4</td><td>P5</td><td>P6</td><td>P7</td><td>P8</td></tr><tr><td>4 (A2; 3 years)</td><td>32.42</td><td>8.19</td><td>4.03</td><td>4.52</td><td>2.56</td><td>0.49<... |
7c7d344aad90ac4a09c99f75a28ff5c82cfe34cac28eaafb12a6ebd34e990f3b.png | simple | <table><tr><td>Essential public health operation</td><td>Climate change and foodborne pathogens example</td></tr><tr><td>1: Food and foodborne disease surveillance</td><td>Enhanced cross country surveillance through the establishment of the European Centre for Disease Prevention and Control. This is tasked with collect... | <table><tr><td>Essential public health operation</td><td>Climate change and foodborne pathogens example</td></tr><tr><td>1: Food and foodborne disease surveillance</td><td>Enhanced cross country surveillance through the establishment of the European Centre for Disease Prevention and Control. This is tasked with collect... | <table><tr><td>4: Health promotion including action to address social determinants and health inequity</td><td>Health promotion campaigns to inform, educate and empower people about health issues that may be associated with climate change</td></tr><tr><td>5: Food and foodborne disease prevention, including early detect... |
dca4d18a7bab8b4d6ee41162be88d556cf6fc959d9488de9bc7652ced3bd278e.png | complex | <table><tr><td rowspan="3">Parental Dietary Pattern</td><td colspan="9">Children’s Dietary Pattern</td></tr><tr><td colspan="3">Sweet & Fat </td><td colspan="3">Ref. Cereals</td><td colspan="3">Animal Products</td></tr><tr><td><i>N</i></td><td>OR</td><td>95%CI</td><td><i>N</i></td><td>OR</td><td>95%CI</td><td... | <table><tr><td rowspan="3">Parental Dietary Pattern</td><td colspan="9">Children’s Dietary Pattern</td></tr><tr><td colspan="3">Sweet & Fat</td><td colspan="3">Ref. Cereals</td><td colspan="3">Animal Products</td></tr><tr><td>N</td><td>OR</td><td>95%CI</td><td>N</td><td>OR</td><td>95%CI</td><td>N</td><td>OR</td><td>95%... | <table><tr><td rowspan="3">Parental Dietary Pattern</td><td colspan="9">Children’s Dietary Pattern</td></tr><tr><td colspan="3">Sweet & Fat</td><td colspan="3">Ref. Cereals</td><td colspan="3">Animal Products</td></tr><tr><td>N</td><td>OR</td><td>95%CI</td><td>N</td><td>OR</td><td>95%CI</td><td>N</td><td>OR</td><td>95%... |
ecd2b9a3146c106f8b54927e8183f65fb34dc197acf2f33ca9c97940f05acc85.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="5">Quintiles of household income per capita (mean values)</td><td rowspan="2">Brazil</td></tr><tr><td>1st</td><td>2nd</td><td>3rd</td><td>4th</td><td>5th</td></tr><tr><td>Area (%)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Rural</td><td>... | <table><tr><td rowspan="2">Variables</td><td colspan="5">Quintiles of household income per capita (mean values)</td><td rowspan="2">Brazil</td></tr><tr><td>1st</td><td>2nd</td><td>3rd</td><td>4th</td><td>5th</td></tr><tr><td>Area (%)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Rural</td><td>3... | <table><tr><td rowspan="2">Variables</td><td colspan="5">Quintiles of household income per capita (mean values)</td><td rowspan="2">Brazil</td></tr><tr><td>1st</td><td>2nd</td><td>3rd</td><td>4th</td><td>5th</td></tr><tr><td>Proportion of women in family unit (%)</td><td>50.7</td><td>51.3</td><td>51.6</td><td>52.7</td>... |
324d0baf45ae208d0950fd2ddf6ba289ba321a79439211f254e0bb2de7494553.png | simple | <table><tr><td>Threshold</td><td>False positives</td><td>True positives</td></tr><tr><td>0</td><td>21.2%</td><td>89.5%</td></tr><tr><td>5</td><td>16.9%</td><td>86.3%</td></tr><tr><td>10</td><td>13.5%</td><td>85.1%</td></tr><tr><td>15</td><td>10.7%</td><td>82.8%</td></tr><tr><td>20</td><td>8.5%</td><td>81.1%</td></tr></... | <table><tr><td>Threshold</td><td>False positives</td></tr><tr><td>0</td><td>21.2%</td></tr><tr><td>5</td><td>16.9%</td></tr><tr><td>10</td><td>13.5%</td></tr><tr><td>15</td><td>10.7%</td></tr><tr><td>20</td><td>8.5%</td></tr></table> | <table><tr><td>True positives</td></tr><tr><td>89.5%</td></tr><tr><td>86.3%</td></tr><tr><td>85.1%</td></tr><tr><td>82.8%</td></tr><tr><td>81.1%</td></tr></table> |
c1c9862447ff78fcf60b338b12577e70c86e43bea49833460d7a56c556247a9e.png | complex | <table><tr><td colspan="2">Additional inclusion criteria</td></tr><tr><td>Pain intensity of 20 mm or more by VAS in the previous 48 hours when walking on a flat surface;At least grade II to III on the Kellgren-Lawrence scale by an X-ray taken within 6 months;</td><td>And reluctant to continue on previous drug but willi... | <table><tr><td colspan="2">Additional inclusion criteria</td></tr><tr><td>Pain intensity of 20 mm or more by VAS in the previous 48 hours when walking on a flat surface;At least grade II to III on the Kellgren-Lawrence scale by an X-ray taken within 6 months;</td><td>And reluctant to continue on previous drug but willi... | <table><tr><td>Exclusion criteria</td><td></td></tr><tr><td colspan="2">Patients presenting with any of the following will be excluded from the study.</td></tr><tr><td>Grade I or Grade IV severity of the index knee based on the Kellgren and Lawrence radiographic criteria as applicable;Use of intra-articular injections ... |
e250d46804dd00b1686f41a4fceb53f1ec25381c3f6ff4ffd256662ffe297628.png | simple | <table><tr><td>Pathway name</td><td>No. genes*</td><td>ES</td><td>NES</td><td>FDR<i>q </i>value</td></tr><tr><td>PHONG_TNF_RESPONSE_VIA_P38_COMPLETE</td><td>13</td><td>0.583</td><td>1.743</td><td>0.580</td></tr><tr><td>DELYS_THYROID_CANCER_DN</td><td>11</td><td>0.612</td><td>1.748</td><td>0.599</td></tr><tr><td>CORRE_M... | <table><tr><td>Pathway name</td><td>No. genes*</td><td>ES</td><td>NES</td><td>FDRq value</td></tr><tr><td>PHONG_TNF_RESPONSE_VIA_P38_COMPLETE</td><td>13</td><td>0.583</td><td>1.743</td><td>0.580</td></tr><tr><td>DELYS_THYROID_CANCER_DN</td><td>11</td><td>0.612</td><td>1.748</td><td>0.599</td></tr><tr><td>CORRE_MULTIPLE... | <table><tr><td>Pathway name</td><td>No. genes*</td><td>ES</td><td>NES</td><td>FDRq value</td></tr><tr><td>WILCOX_PRESPONSE_TO_ROGESTERONE_UP</td><td>6</td><td>0.705</td><td>1.700</td><td>0.621</td></tr><tr><td>WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN</td><td>13</td><td>0.562</td><td>1.674</td><td>0.632</td></tr><tr><td>KEGG_R... |
27afb5d6c4117421aea6c7dc5b1849ef4945f58e6be4693434eabc8ef662922e.png | simple | <table><tr><td>N = 7</td><td>Mean</td><td>SD</td><td>Range</td></tr><tr><td>Age [yrs]</td><td>71.3</td><td>8.3</td><td>59-85</td></tr><tr><td>Height [cm]</td><td>171</td><td>5.6</td><td>163.0-177.0</td></tr><tr><td>Weight [kg]</td><td>70.85</td><td>10.1</td><td>58.0-90.0</td></tr><tr><td>BMI [kg/m<sup>2</sup>]</td><td>... | <table><tr><td>N = 7</td><td>Mean</td><td>SD</td></tr><tr><td>Age [yrs]</td><td>71.3</td><td>8.3</td></tr><tr><td>Height [cm]</td><td>171</td><td>5.6</td></tr><tr><td>Weight [kg]</td><td>70.85</td><td>10.1</td></tr><tr><td>BMI [kg/m2]</td><td>25.1</td><td>4.5</td></tr><tr><td>MOCA [0-30]</td><td>21.4</td><td>1.4</td></... | <table><tr><td>Range</td></tr><tr><td>59-85</td></tr><tr><td>163.0-177.0</td></tr><tr><td>58.0-90.0</td></tr><tr><td>21.7-33.9</td></tr><tr><td>20-24</td></tr><tr><td>47-70</td></tr><tr><td>4-19</td></tr><tr><td>2-3</td></tr></table> |
3fc626c5025803112d7d3c147679e9a071f35a90c60d9c65df957e465ffa40a2.png | simple | <table><tr><td></td><td>Harar HDSS</td><td>Kersa HDSS</td><td>Oromia*</td><td>Ethiopia*</td></tr><tr><td>TFR</td><td>1.9</td><td>5.3</td><td>4.85</td><td>4.8</td></tr><tr><td>GFR</td><td>64</td><td>166.8</td><td>153.30</td><td>128.80</td></tr><tr><td>CBR</td><td>20.3</td><td>37.2</td><td>33.90</td><td>30.10</td></tr></... | <table><tr><td></td><td>Harar HDSS</td><td>Kersa HDSS</td></tr><tr><td>TFR</td><td>1.9</td><td>5.3</td></tr><tr><td>GFR</td><td>64</td><td>166.8</td></tr><tr><td>CBR</td><td>20.3</td><td>37.2</td></tr></table> | <table><tr><td>Oromia*</td><td>Ethiopia*</td></tr><tr><td>4.85</td><td>4.8</td></tr><tr><td>153.30</td><td>128.80</td></tr><tr><td>33.90</td><td>30.10</td></tr></table> |
daa89b1add79dcd4fc7b967f7c09d6f2db8560be5a27fdc2b41bbafb9c822e28.png | complex | <table><tr><td></td><td colspan="2">AMSA NaCl</td><td colspan="2">AMSA EPI All</td><td>P-value</td><td colspan="2">AMSA EPI 0.02 mg/kg/dose</td><td>P-value</td><td colspan="2">AMSA EPI 0.03 mg/kg/dose</td><td>P-value</td></tr><tr><td>MCC 20 s</td><td>12.1</td><td>(9.6-14.0)<sup>b</sup></td><td>13.0</td><td>(10.9-16.0)<... | <table><tr><td></td><td colspan="2">AMSA NaCl</td><td colspan="2">AMSA EPI All</td><td>P-value</td><td colspan="2">AMSA EPI 0.02 mg/kg/dose</td><td>P-value</td><td colspan="2">AMSA EPI 0.03 mg/kg/dose</td><td>P-value</td></tr><tr><td>MCC 20 s</td><td>12.1</td><td>(9.6-14.0)b</td><td>13.0</td><td>(10.9-16.0)d</td><td>0.... | <table><tr><td></td><td colspan="2">AMSA NaCl</td><td colspan="2">AMSA EPI All</td><td>P-value</td><td colspan="2">AMSA EPI 0.02 mg/kg/dose</td><td>P-value</td><td colspan="2">AMSA EPI 0.03 mg/kg/dose</td><td>P-value</td></tr><tr><td>Inj #1</td><td>14.3</td><td>(12.7-16.8)b</td><td>15.9</td><td>(13.9-16.7)d</td><td>0.4... |
a6ce7ec5aee044977a4823a675d9d9a4cca994919033c4b400ef8421e183bfe3.png | simple | <table><tr><td>Reference value</td><td>day 1</td><td>day 2</td><td>day 5</td><td>day 8</td><td>day 11</td><td>day 15</td><td>day 21</td><td>day 28</td></tr><tr><td>PLT:100–400 *10<sup>9</sup>/L</td><td>48</td><td>37</td><td>12</td><td>106</td><td>173</td><td>177</td><td>212</td><td><i>268</i></td></tr><tr><td>HB:... | <table><tr><td>Reference value</td><td>day 1</td><td>day 2</td><td>day 5</td><td>day 8</td><td>day 11</td><td>day 15</td><td>day 21</td><td>day 28</td></tr></table> | <table><tr><td>PLT:100–400 *109/L</td><td>48</td><td>37</td><td>12</td><td>106</td><td>173</td><td>177</td><td>212</td><td>268</td></tr><tr><td>HB:110–155 g/L</td><td>79</td><td>75</td><td>85</td><td>86</td><td>87</td><td>91</td><td>105</td><td>119</td></tr><tr><td>ESR:0–20 mm/h</td><td></td><td>56</td><td>122</td><td>... |
f6703c5eb83b9bc287e43862e7bdb2bb7c7e6cc38fef8c9c73a5d560412d9699.png | complex | <table><tr><td rowspan="3">Model description</td><td rowspan="3">Category</td><td rowspan="3">Numberof deaths</td><td rowspan="3">Person-years</td><td colspan="2">SPM (μg/m<sup>3</sup>)</td><td colspan="2">PM<sub>2.5</sub> (μg/m<sup>3</sup>)<sup>b</sup></td><td colspan="2">SO<sub>2</sub> (ppb)</td><td colspan... | <table><tr><td rowspan="3">Model description</td><td rowspan="3">Category</td><td rowspan="3">Numberof deaths</td><td rowspan="3">Person-years</td><td colspan="2">SPM (μg/m3)</td><td colspan="2">PM2.5 (μg/m3)b</td><td colspan="2">SO2 (ppb)</td><td colspan="2">NO2 (ppb)</td></tr><tr><td>HR</td><td>95% CI</td><td>HR</td>... | <table><tr><td rowspan="3">Model description</td><td rowspan="3">Category</td><td rowspan="3">Numberof deaths</td><td rowspan="3">Person-years</td><td colspan="2">SPM (μg/m3)</td><td colspan="2">PM2.5 (μg/m3)b</td><td colspan="2">SO2 (ppb)</td><td colspan="2">NO2 (ppb)</td></tr><tr><td>HR</td><td>95% CI</td><td>HR</td>... |
b6fd683eab5ed5190ef352e78ff21f19a188c3f725e59e1a3e437ae706fb88e4.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">IMRT</td><td colspan="2">3DRT</td></tr><tr><td>Mean maximum</td><td>Mean average</td><td>Mean maximum</td><td>Mean average</td></tr><tr><td colspan="5">Tongue cancer</td></tr><tr><td colspan="5"> Lower teeth</td></tr><tr><td>Anterior</td><td>56.9</td><td>42.8</td><td>36.4... | <table><tr><td rowspan="2"></td><td colspan="2">IMRT</td><td colspan="2">3DRT</td></tr><tr><td>Mean maximum</td><td>Mean average</td><td>Mean maximum</td><td>Mean average</td></tr><tr><td colspan="5">Tongue cancer</td></tr><tr><td colspan="5">Lower teeth</td></tr><tr><td>Anterior</td><td>56.9</td><td>42.8</td><td>36.4<... | <table><tr><td rowspan="2"></td><td colspan="2">IMRT</td><td colspan="2">3DRT</td></tr><tr><td>Mean maximum</td><td>Mean average</td><td>Mean maximum</td><td>Mean average</td></tr><tr><td>Pre-molars</td><td>42.7</td><td>36.1</td><td>20.9</td><td>16.8</td></tr><tr><td>Molars</td><td>47.5</td><td>36.7</td><td>43.7</td><t... |
1d746620634e5f9032ead48d3b70d931ba948b1f71f4a844d9ab368f4d5e8b26.png | simple | <table><tr><td> </td><td>Number of subjects</td><td>Mean</td><td>Standard deviation</td><td>Median</td><td>Minimum</td><td>Maximum</td></tr><tr><td>Age (years)</td><td>98</td><td>36.00</td><td>8.44</td><td>37.00</td><td>18.00</td><td>50.00</td></tr><tr><td>Height (cm)</td><td>98</td><td>158.67</td><td>5.19</td><td>158.... | <table><tr><td></td><td>Number of subjects</td><td>Mean</td><td>Standard deviation</td><td>Median</td><td>Minimum</td><td>Maximum</td></tr><tr><td>Age (years)</td><td>98</td><td>36.00</td><td>8.44</td><td>37.00</td><td>18.00</td><td>50.00</td></tr></table> | <table><tr><td></td><td>Number of subjects</td><td>Mean</td><td>Standard deviation</td><td>Median</td><td>Minimum</td><td>Maximum</td></tr><tr><td>Height (cm)</td><td>98</td><td>158.67</td><td>5.19</td><td>158.35</td><td>146.00</td><td>169.60</td></tr><tr><td>Weight (kg)</td><td>98</td><td>81.84</td><td>19.32</td><td>8... |
1de2e5f8439f8e4804b1b08ce189022d79bee4ba313db117f061c664a510e699.png | simple | <table><tr><td>Scoring used in the study</td><td></td></tr><tr><td>The patient has resumed work-related and other activities with slight or no symptoms.</td><td>3: Excellent</td></tr><tr><td>The patient has resumed work-related and other activities but occasionally feels pain in the back or lower limbs after strenuous ... | <table><tr><td>Scoring used in the study</td><td></td></tr><tr><td>The patient has resumed work-related and other activities with slight or no symptoms.</td><td>3: Excellent</td></tr><tr><td>The patient has resumed work-related and other activities but occasionally feels pain in the back or lower limbs after strenuous ... | <table><tr><td>Scoring used in the study</td></tr><tr><td>rry out activities of daily living and is considered to be disabled.</td></tr></table> |
3919eeac5edf42d11b78777feaac1028aaa9a590f560c01dd9ed26f6c55fdac4.png | complex | <table><tr><td colspan="6">Exocyclic M<sub>1</sub>dG and 8-oxodG Adducts</td></tr><tr><td></td><td><i>N</i></td><td>M<sub>1</sub>dG ± SE</td><td><i>p</i>-Value</td><td>8-oxodG ± SE</td><td><i>p</i>-Value</td></tr><tr><td colspan="6">Adduct background in presence or absence of AMF exposures</td></tr><tr><td>Co... | <table><tr><td colspan="3">Exocyclic M1dG and 8-oxodG Adducts</td></tr><tr><td></td><td>N</td><td>M1dG ± SE</td></tr><tr><td colspan="3">Adduct background in presence or absence of AMF exposures</td></tr><tr><td>Control cells</td><td></td><td></td></tr><tr><td>Nonexposed to AMF</td><td></td><td></td></tr><tr><td>Incuba... | <table><tr><td colspan="3">Exocyclic M1dG and 8-oxodG Adducts</td></tr><tr><td>p-Value</td><td>8-oxodG ± SE</td><td>p-Value</td></tr><tr><td colspan="3">Adduct background in presence or absence of AMF exposures</td></tr><tr><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td></tr><tr><td></td><td></td><td></... |
ed64c6bc0f092927b5d14594e0f4f93aa4bffbc2c61ae8c244369bc7986a1260.png | complex | <table><tr><td rowspan="2">StandardOrder </td><td rowspan="2">Isoeugenol</td><td rowspan="2">Tween 80</td><td rowspan="2">NaCl</td><td rowspan="2">Dry Biomass</td><td colspan="2">Vanillin yield (g/L)</td></tr><tr><td>Observed</td><td>Predicted</td></tr><tr><td>1</td><td>-1</td><td>-1</td><td>0</td><td>0</td><td>1.53</t... | <table><tr><td rowspan="2">StandardOrder</td><td rowspan="2">Isoeugenol</td><td rowspan="2">Tween 80</td><td rowspan="2">NaCl</td><td rowspan="2">Dry Biomass</td><td>Vanillin yield (g/L)</td></tr><tr><td>Observed</td></tr><tr><td>1</td><td>-1</td><td>-1</td><td>0</td><td>0</td><td>1.53</td></tr><tr><td>2</td><td>+1</td... | <table><tr><td>Vanillin yield (g/L)</td></tr><tr><td>Predicted</td></tr><tr><td>1.48</td></tr><tr><td>1.78</td></tr><tr><td>1.11</td></tr><tr><td>1.96</td></tr><tr><td>1.73</td></tr><tr><td>1.37</td></tr><tr><td>1.25</td></tr><tr><td>2.16</td></tr><tr><td>1.63</td></tr><tr><td>1.89</td></tr><tr><td>1.47</td></tr><tr><t... |
9b7c48fe0b0cb481a5dfde20715b25ce7642e8cd8825eb1e3d5d5d93b515f60c.png | complex | <table><tr><td>Time (days)</td><td>Treatment</td><td>Calcium (mg/dl)</td></tr><tr><td rowspan="2">21</td><td>Control</td><td>9.468 ± 0.275</td></tr><tr><td>Osteoinduced</td><td>13.496 ± 0.892**</td></tr></table> | <table><tr><td>Time (days)</td><td>Treatment</td><td>Calcium (mg/dl)</td></tr><tr><td>21</td><td>Control</td><td>9.468 ± 0.275</td></tr></table> | <table><tr><td>Time (days)</td><td>Treatment</td><td>Calcium (mg/dl)</td></tr><tr><td>21</td><td>Osteoinduced</td><td>13.496 ± 0.892**</td></tr></table> |
8b1a5f3d1706a2f250d06ac196a7e9ef48c0637611810b5531aec413a327152a.png | simple | <table><tr><td> </td><td>Pre-injury</td><td>5-months post-injury</td><td>12-months post-injury</td><td>NZ general population survey</td></tr><tr><td>Total</td><td>2842</td><td>1470</td><td>2262</td><td>1250</td></tr><tr><td>Age:</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>18-24</td><td>14.4%</td><td>13.1%<... | <table><tr><td></td></tr><tr><td>Total</td></tr><tr><td>Age:</td></tr><tr><td>18-24</td></tr><tr><td>25-34</td></tr><tr><td>35-44</td></tr><tr><td>45-54</td></tr><tr><td>55-64</td></tr><tr><td>65+</td></tr><tr><td>Not reported</td></tr><tr><td>Sex:</td></tr><tr><td>Male</td></tr><tr><td>Female</td></tr><tr><td>Not repo... | <table><tr><td>Pre-injury</td><td>5-months post-injury</td><td>12-months post-injury</td><td>NZ general population survey</td></tr><tr><td>2842</td><td>1470</td><td>2262</td><td>1250</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td>14.4%</td><td>13.1%</td><td>12.1%</td><td>7.0%</td></tr><tr><td>20.8%</td><... |
26db279fc0cedcd0b04a9c861b3a86962212a99a8b4982bee860de6a4a329f9d.png | simple | <table><tr><td>Classifier</td><td>Accuracy (%)</td><td>Sensitivity (%)</td><td>Specificity (%)</td><td>Strength (%)</td><td>ROCAUC</td></tr><tr><td>BindN-RF</td><td>80.00</td><td>73.08</td><td>80.63</td><td>76.86</td><td>0.8495</td></tr><tr><td>BindN</td><td>70.81</td><td>68.70</td><td>71.01</td><td>69.85</td><td>0.764... | <table><tr><td>Classifier</td><td>Accuracy (%)</td><td>Sensitivity (%)</td><td>Specificity (%)</td><td>Strength (%)</td><td>ROCAUC</td></tr><tr><td>BindN-RF</td><td>80.00</td><td>73.08</td><td>80.63</td><td>76.86</td><td>0.8495</td></tr></table> | <table><tr><td>BindN</td><td>70.81</td><td>68.70</td><td>71.01</td><td>69.85</td><td>0.7648</td></tr><tr><td>DP-Bind</td><td>78.89</td><td>65.89</td><td>80.76</td><td>73.32</td><td>0.8149</td></tr><tr><td>DBS-PSSM</td><td>67.91</td><td>37.48</td><td>70.72</td><td>54.10</td><td>0.5528</td></tr></table> |
13dcfa0b696cfa8384a99921f9e739a75206f78d23de7bca5cde5f6a34f6b597.png | complex | <table><tr><td rowspan="2">The Tested Compounds </td><td colspan="3">Side Effects of Rats Treated with Artesunate and Artemisinin, Respectively</td></tr><tr><td>The Loss of Body Weight</td><td>Vomiting</td><td>Diarrhea</td></tr><tr><td>Artesunate</td><td>−</td><td>−</td><td>−</td></tr><tr><td>Artemisi... | <table><tr><td rowspan="2">The Tested Compounds</td><td colspan="3">Side Effects of Rats Treated with Artesunate and Artemisinin, Respectively</td></tr><tr><td>The Loss of Body Weight</td><td>Vomiting</td><td>Diarrhea</td></tr><tr><td>Artesunate</td><td>−</td><td>−</td><td>−</td></tr></table> | <table><tr><td rowspan="2">The Tested Compounds</td><td colspan="3">Side Effects of Rats Treated with Artesunate and Artemisinin, Respectively</td></tr><tr><td>The Loss of Body Weight</td><td>Vomiting</td><td>Diarrhea</td></tr><tr><td>Artemisinin</td><td>−</td><td>−</td><td>−</td></tr></table> |
e4e6f457c77217aefb1c9f1baf6b2811ba1080e18282cf1400024d772ebd060f.png | simple | <table><tr><td>Characteristics</td><td>Frequencies (n=271)</td><td>Percentage (%)</td></tr><tr><td>Household Members Ever Suffer Jigger Infestation:</td><td></td><td></td></tr><tr><td>Yes</td><td>239</td><td>88.2</td></tr><tr><td>Households reported with jiggers infested persons:</td><td></td><td></td></tr><tr><td>Yes<... | <table><tr><td>Characteristics</td><td>Frequencies (n=271)</td><td>Percentage (%)</td></tr><tr><td>Household Members Ever Suffer Jigger Infestation:</td><td></td><td></td></tr><tr><td>Yes</td><td>239</td><td>88.2</td></tr><tr><td>Households reported with jiggers infested persons:</td><td></td><td></td></tr><tr><td>Yes<... | <table><tr><td>Characteristics</td><td>Frequencies (n=271)</td><td>Percentage (%)</td></tr><tr><td>Yes</td><td>51</td><td>18.8</td></tr><tr><td>Number of infested household members</td><td></td><td></td></tr><tr><td>1Person</td><td>32</td><td>11.8</td></tr><tr><td>2 Persons</td><td>15</td><td>5.5</td></tr><tr><td>3 Per... |
351c112b5b619da781f6b0b0b7e540bcf34218c7e9b9949059c2b058dd659c12.png | complex | <table><tr><td rowspan="3">Severity of retinopathy</td><td colspan="7">Retinal findings in severe malaria (indirect ophthalmoscopy; <i>n</i> = 139)</td></tr><tr><td rowspan="2">Any retinopathy</td><td colspan="2">Hemorrhages</td><td rowspan="2">Papilloedema*</td><td colspan="3">Whitening</td></tr><tr><td>White-centered... | <table><tr><td rowspan="3">Severity of retinopathy</td><td colspan="7">Retinal findings in severe malaria (indirect ophthalmoscopy; n = 139)</td></tr><tr><td rowspan="2">Any retinopathy</td><td colspan="2">Hemorrhages</td><td rowspan="2">Papilloedema*</td><td colspan="3">Whitening</td></tr><tr><td>White-centered</td><t... | <table><tr><td></td><td>6 (29%)</td><td></td><td>(38%)</td><td></td><td> (0%)</td><td>0%)</td><td>0%)</td></tr><tr><td>Moderate to severe</td><td>12 (57%)</td><td>0 (0%)</td><td>8 (38%)</td><td>9 (43%)</td><td>2 (10%)</td><td>1 (5%)</td><td>2 (10%)</td></tr><tr><td>Total</td><td>18 (86%)</td><td>15 (71%)</td><td>16 (76... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.